| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Macular Degeneration | 36 | 2024 | 1015 | 6.060 |
Why?
|
| Breast Neoplasms | 216 | 2024 | 21207 | 4.490 |
Why?
|
| Nurses | 104 | 2024 | 2501 | 2.900 |
Why?
|
| Diet | 122 | 2024 | 8089 | 2.680 |
Why?
|
| Models, Statistical | 56 | 2023 | 5107 | 2.520 |
Why?
|
| Postmenopause | 67 | 2024 | 2518 | 2.260 |
Why?
|
| Biostatistics | 5 | 2024 | 163 | 2.230 |
Why?
|
| Risk Factors | 440 | 2024 | 74944 | 2.220 |
Why?
|
| Premenopause | 48 | 2024 | 1039 | 2.200 |
Why?
|
| Menopause | 55 | 2024 | 1656 | 2.190 |
Why?
|
| Receptors, Progesterone | 25 | 2024 | 1160 | 2.170 |
Why?
|
| Glaucoma, Open-Angle | 26 | 2023 | 742 | 1.950 |
Why?
|
| Prospective Studies | 405 | 2024 | 54924 | 1.950 |
Why?
|
| Body Mass Index | 104 | 2025 | 13053 | 1.890 |
Why?
|
| Receptors, Estrogen | 27 | 2024 | 2253 | 1.840 |
Why?
|
| Statistics, Nonparametric | 13 | 2021 | 2862 | 1.740 |
Why?
|
| Blood Pressure | 77 | 2025 | 8543 | 1.740 |
Why?
|
| Retinitis Pigmentosa | 28 | 2018 | 395 | 1.710 |
Why?
|
| Eye Diseases | 8 | 2024 | 660 | 1.630 |
Why?
|
| Dietary Fats | 44 | 2022 | 2003 | 1.630 |
Why?
|
| Female | 858 | 2025 | 397187 | 1.620 |
Why?
|
| Mammography | 30 | 2024 | 2433 | 1.560 |
Why?
|
| Middle Aged | 676 | 2025 | 223487 | 1.560 |
Why?
|
| Smoking | 113 | 2020 | 9092 | 1.540 |
Why?
|
| Breast | 28 | 2024 | 1976 | 1.480 |
Why?
|
| Carotenoids | 29 | 2022 | 620 | 1.440 |
Why?
|
| Biometry | 15 | 2019 | 570 | 1.440 |
Why?
|
| Diet Records | 21 | 2024 | 426 | 1.430 |
Why?
|
| Breast Diseases | 17 | 2021 | 442 | 1.410 |
Why?
|
| Humans | 1073 | 2025 | 768171 | 1.410 |
Why?
|
| Feeding Behavior | 48 | 2021 | 3205 | 1.400 |
Why?
|
| Alcohol Drinking | 62 | 2023 | 4045 | 1.400 |
Why?
|
| Adult | 664 | 2025 | 223646 | 1.360 |
Why?
|
| Weight Gain | 27 | 2024 | 2359 | 1.330 |
Why?
|
| Complement Factor H | 15 | 2020 | 110 | 1.330 |
Why?
|
| Follow-Up Studies | 209 | 2023 | 39354 | 1.320 |
Why?
|
| Proportional Hazards Models | 101 | 2024 | 12543 | 1.310 |
Why?
|
| Retinal Drusen | 5 | 2020 | 78 | 1.290 |
Why?
|
| Contact Lenses, Hydrophilic | 4 | 2022 | 53 | 1.290 |
Why?
|
| Hypertension | 74 | 2025 | 8616 | 1.280 |
Why?
|
| Regression Analysis | 55 | 2017 | 6340 | 1.260 |
Why?
|
| Contraceptives, Oral | 37 | 2021 | 560 | 1.250 |
Why?
|
| Incidence | 152 | 2024 | 21538 | 1.230 |
Why?
|
| Risk Assessment | 74 | 2024 | 24318 | 1.170 |
Why?
|
| Visual Acuity | 32 | 2020 | 2714 | 1.150 |
Why?
|
| Ovarian Neoplasms | 38 | 2023 | 4916 | 1.150 |
Why?
|
| Parity | 32 | 2024 | 931 | 1.120 |
Why?
|
| Vegetables | 28 | 2024 | 1199 | 1.110 |
Why?
|
| Aged | 332 | 2024 | 171502 | 1.080 |
Why?
|
| Polymorphism, Single Nucleotide | 38 | 2020 | 16044 | 1.080 |
Why?
|
| Cluster Analysis | 9 | 2019 | 2732 | 1.050 |
Why?
|
| Case-Control Studies | 120 | 2024 | 22290 | 1.050 |
Why?
|
| Adiposity | 15 | 2022 | 1895 | 1.050 |
Why?
|
| Ophthalmology | 7 | 2024 | 560 | 1.010 |
Why?
|
| Diet Surveys | 36 | 2024 | 1160 | 0.990 |
Why?
|
| Geographic Atrophy | 5 | 2018 | 92 | 0.980 |
Why?
|
| Longitudinal Studies | 72 | 2024 | 14783 | 0.970 |
Why?
|
| Visual Fields | 22 | 2022 | 1065 | 0.970 |
Why?
|
| Estrogen Replacement Therapy | 32 | 2018 | 1209 | 0.960 |
Why?
|
| Fruit | 27 | 2021 | 1165 | 0.940 |
Why?
|
| Data Interpretation, Statistical | 16 | 2018 | 2709 | 0.930 |
Why?
|
| Reproductive History | 10 | 2024 | 210 | 0.920 |
Why?
|
| Multivariate Analysis | 77 | 2021 | 12077 | 0.920 |
Why?
|
| Electroretinography | 17 | 2018 | 524 | 0.910 |
Why?
|
| Lutein | 9 | 2024 | 123 | 0.900 |
Why?
|
| Blood Pressure Determination | 20 | 2020 | 646 | 0.890 |
Why?
|
| Disease Progression | 32 | 2024 | 13668 | 0.890 |
Why?
|
| Life Style | 31 | 2024 | 3932 | 0.880 |
Why?
|
| Antioxidants | 15 | 2018 | 1676 | 0.880 |
Why?
|
| Menarche | 19 | 2024 | 538 | 0.870 |
Why?
|
| Likelihood Functions | 12 | 2023 | 994 | 0.870 |
Why?
|
| Obesity | 45 | 2025 | 13091 | 0.860 |
Why?
|
| Dietary Fiber | 19 | 2016 | 767 | 0.850 |
Why?
|
| Nutrition Assessment | 11 | 2020 | 740 | 0.850 |
Why?
|
| Proteins | 14 | 2020 | 6009 | 0.850 |
Why?
|
| Vitamin A | 23 | 2018 | 611 | 0.840 |
Why?
|
| Cohort Studies | 173 | 2024 | 41753 | 0.840 |
Why?
|
| United States | 220 | 2024 | 73039 | 0.840 |
Why?
|
| Male | 434 | 2025 | 364731 | 0.830 |
Why?
|
| Diabetic Retinopathy | 8 | 2023 | 1300 | 0.810 |
Why?
|
| Intraocular Pressure | 17 | 2022 | 1304 | 0.800 |
Why?
|
| Fatty Acids, Omega-3 | 15 | 2024 | 1399 | 0.800 |
Why?
|
| Risk | 126 | 2020 | 9613 | 0.790 |
Why?
|
| Epidemiologic Methods | 22 | 2021 | 1328 | 0.780 |
Why?
|
| Anti-Mullerian Hormone | 7 | 2022 | 420 | 0.780 |
Why?
|
| Flavonoids | 7 | 2021 | 447 | 0.760 |
Why?
|
| Energy Intake | 40 | 2022 | 2146 | 0.750 |
Why?
|
| Age Factors | 120 | 2024 | 18415 | 0.740 |
Why?
|
| Menopause, Premature | 6 | 2019 | 124 | 0.730 |
Why?
|
| Lymphoma, Non-Hodgkin | 9 | 2022 | 1375 | 0.720 |
Why?
|
| Vision Disorders | 10 | 2022 | 1092 | 0.720 |
Why?
|
| Nuts | 8 | 2021 | 264 | 0.720 |
Why?
|
| Body Weight | 42 | 2019 | 4627 | 0.720 |
Why?
|
| Diet, Mediterranean | 10 | 2022 | 748 | 0.710 |
Why?
|
| Hypertension, Pregnancy-Induced | 6 | 2022 | 529 | 0.710 |
Why?
|
| Exercise | 31 | 2024 | 5954 | 0.690 |
Why?
|
| Diabetes Mellitus, Type 2 | 38 | 2024 | 12252 | 0.690 |
Why?
|
| ROC Curve | 14 | 2023 | 3628 | 0.680 |
Why?
|
| Ophthalmoscopy | 1 | 2020 | 172 | 0.680 |
Why?
|
| Trans Fatty Acids | 5 | 2022 | 155 | 0.670 |
Why?
|
| Vitamin D | 13 | 2022 | 3311 | 0.670 |
Why?
|
| Disease Susceptibility | 5 | 2020 | 1793 | 0.670 |
Why?
|
| Colorectal Neoplasms | 24 | 2023 | 6975 | 0.670 |
Why?
|
| Research Design | 22 | 2024 | 6209 | 0.660 |
Why?
|
| Survival Analysis | 20 | 2023 | 10099 | 0.660 |
Why?
|
| Prolactin | 9 | 2024 | 627 | 0.650 |
Why?
|
| Adolescent | 183 | 2024 | 89169 | 0.650 |
Why?
|
| Cataract | 21 | 2023 | 837 | 0.630 |
Why?
|
| Optic Neuritis | 1 | 2021 | 175 | 0.630 |
Why?
|
| Odds Ratio | 52 | 2024 | 9669 | 0.630 |
Why?
|
| Endometrial Neoplasms | 11 | 2023 | 1382 | 0.630 |
Why?
|
| Folic Acid | 16 | 2019 | 1337 | 0.610 |
Why?
|
| Botulinum Toxins, Type A | 2 | 2017 | 238 | 0.590 |
Why?
|
| Aspirin | 24 | 2022 | 3135 | 0.580 |
Why?
|
| Breast Feeding | 10 | 2021 | 1363 | 0.580 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 5 | 2021 | 252 | 0.580 |
Why?
|
| Piriformis Muscle Syndrome | 1 | 2017 | 3 | 0.580 |
Why?
|
| Sterilization, Tubal | 7 | 2021 | 78 | 0.570 |
Why?
|
| Logistic Models | 50 | 2024 | 13290 | 0.570 |
Why?
|
| Genetic Predisposition to Disease | 28 | 2021 | 18065 | 0.570 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 14 | 2022 | 2271 | 0.570 |
Why?
|
| Complement C3 | 8 | 2020 | 434 | 0.560 |
Why?
|
| Nutrition Surveys | 16 | 2020 | 1738 | 0.560 |
Why?
|
| Caffeine | 9 | 2019 | 703 | 0.540 |
Why?
|
| Anthropometry | 15 | 2024 | 1346 | 0.540 |
Why?
|
| Ascorbic Acid | 10 | 2022 | 658 | 0.540 |
Why?
|
| Exfoliation Syndrome | 3 | 2022 | 113 | 0.540 |
Why?
|
| Cause of Death | 19 | 2021 | 3721 | 0.540 |
Why?
|
| Zinc Compounds | 1 | 2016 | 36 | 0.540 |
Why?
|
| Dietary Carbohydrates | 11 | 2021 | 896 | 0.530 |
Why?
|
| Retina | 9 | 2021 | 2662 | 0.530 |
Why?
|
| Estrogens | 21 | 2021 | 1536 | 0.530 |
Why?
|
| Diabetes, Gestational | 9 | 2024 | 1263 | 0.520 |
Why?
|
| Genotype | 33 | 2018 | 13045 | 0.520 |
Why?
|
| Computer Simulation | 13 | 2023 | 6283 | 0.520 |
Why?
|
| Coronary Disease | 45 | 2022 | 5919 | 0.520 |
Why?
|
| Cardiovascular Diseases | 46 | 2025 | 15662 | 0.510 |
Why?
|
| Aged, 80 and over | 77 | 2024 | 59626 | 0.510 |
Why?
|
| Vitamin B Complex | 6 | 2019 | 299 | 0.500 |
Why?
|
| Coffee | 9 | 2021 | 594 | 0.500 |
Why?
|
| Time Factors | 94 | 2020 | 40220 | 0.500 |
Why?
|
| Diseases in Twins | 2 | 2008 | 447 | 0.500 |
Why?
|
| Retinopathy of Prematurity | 1 | 2020 | 449 | 0.500 |
Why?
|
| Fish Products | 2 | 2006 | 31 | 0.500 |
Why?
|
| Collagen Type VIII | 2 | 2016 | 15 | 0.490 |
Why?
|
| Nutritional Status | 6 | 2024 | 1628 | 0.490 |
Why?
|
| Neuromuscular Agents | 1 | 2017 | 148 | 0.490 |
Why?
|
| Sample Size | 6 | 2024 | 846 | 0.490 |
Why?
|
| Ovulation | 8 | 2009 | 181 | 0.490 |
Why?
|
| Refractive Errors | 2 | 2017 | 148 | 0.490 |
Why?
|
| Pregnancy | 73 | 2024 | 30255 | 0.480 |
Why?
|
| Area Under Curve | 10 | 2021 | 1643 | 0.480 |
Why?
|
| Hysterectomy | 9 | 2013 | 863 | 0.480 |
Why?
|
| Chronic Disease | 14 | 2020 | 9384 | 0.480 |
Why?
|
| Work Schedule Tolerance | 7 | 2019 | 553 | 0.480 |
Why?
|
| Health Personnel | 19 | 2019 | 3384 | 0.470 |
Why?
|
| Anion Exchange Resins | 1 | 2014 | 10 | 0.460 |
Why?
|
| Lipase | 3 | 2011 | 321 | 0.460 |
Why?
|
| Colestipol | 1 | 2014 | 11 | 0.460 |
Why?
|
| Retinal Dehydrogenase | 2 | 2024 | 78 | 0.460 |
Why?
|
| Imidazolidines | 3 | 2004 | 38 | 0.460 |
Why?
|
| beta Carotene | 16 | 2015 | 523 | 0.450 |
Why?
|
| Eating | 11 | 2022 | 1542 | 0.450 |
Why?
|
| Pre-Eclampsia | 6 | 2022 | 1255 | 0.450 |
Why?
|
| Waist Circumference | 7 | 2022 | 935 | 0.440 |
Why?
|
| Dietary Supplements | 21 | 2022 | 3445 | 0.440 |
Why?
|
| Environment | 6 | 2015 | 1121 | 0.440 |
Why?
|
| Macula Lutea | 1 | 2015 | 180 | 0.440 |
Why?
|
| Body Constitution | 6 | 2003 | 273 | 0.440 |
Why?
|
| Models, Theoretical | 8 | 2019 | 3573 | 0.430 |
Why?
|
| Twins, Monozygotic | 5 | 2011 | 472 | 0.430 |
Why?
|
| Physical Therapy Modalities | 1 | 2017 | 533 | 0.430 |
Why?
|
| Confidence Intervals | 21 | 2020 | 2923 | 0.430 |
Why?
|
| Protoporphyria, Erythropoietic | 1 | 2014 | 54 | 0.430 |
Why?
|
| Insulin-Like Growth Factor I | 9 | 2014 | 1942 | 0.420 |
Why?
|
| Food | 7 | 2024 | 768 | 0.420 |
Why?
|
| Dairy Products | 7 | 2019 | 490 | 0.420 |
Why?
|
| Models, Biological | 14 | 2018 | 9497 | 0.410 |
Why?
|
| Women's Health | 17 | 2024 | 2082 | 0.410 |
Why?
|
| Colonic Neoplasms | 9 | 2018 | 2541 | 0.410 |
Why?
|
| Eggs | 5 | 2020 | 182 | 0.400 |
Why?
|
| Mammary Glands, Human | 6 | 2015 | 202 | 0.400 |
Why?
|
| Infertility, Female | 10 | 2015 | 763 | 0.400 |
Why?
|
| Vitamins | 15 | 2022 | 1638 | 0.400 |
Why?
|
| Smoking Cessation | 15 | 2018 | 2085 | 0.400 |
Why?
|
| Bayes Theorem | 2 | 2018 | 2359 | 0.400 |
Why?
|
| Gonadal Steroid Hormones | 6 | 2019 | 707 | 0.400 |
Why?
|
| Diet Therapy | 3 | 2021 | 150 | 0.400 |
Why?
|
| Tomography, Optical Coherence | 6 | 2021 | 2957 | 0.400 |
Why?
|
| Resource Allocation | 1 | 2014 | 354 | 0.390 |
Why?
|
| Child Welfare | 2 | 2024 | 523 | 0.390 |
Why?
|
| Self Report | 13 | 2019 | 3773 | 0.390 |
Why?
|
| Algorithms | 14 | 2023 | 14164 | 0.390 |
Why?
|
| Body Size | 5 | 2022 | 463 | 0.390 |
Why?
|
| Reproducibility of Results | 39 | 2024 | 20225 | 0.390 |
Why?
|
| Dietary Proteins | 8 | 2022 | 960 | 0.390 |
Why?
|
| Meat | 8 | 2023 | 588 | 0.390 |
Why?
|
| Neoplasms, Glandular and Epithelial | 5 | 2014 | 489 | 0.380 |
Why?
|
| Birth Weight | 11 | 2022 | 2121 | 0.370 |
Why?
|
| Railroads | 3 | 2006 | 63 | 0.370 |
Why?
|
| Child | 107 | 2024 | 80917 | 0.370 |
Why?
|
| Betaine | 1 | 2011 | 90 | 0.370 |
Why?
|
| Prognosis | 39 | 2024 | 30009 | 0.370 |
Why?
|
| Methionine | 4 | 2013 | 573 | 0.360 |
Why?
|
| Health Surveys | 25 | 2020 | 4057 | 0.360 |
Why?
|
| Fibrocystic Breast Disease | 5 | 2013 | 103 | 0.360 |
Why?
|
| Matched-Pair Analysis | 2 | 2006 | 285 | 0.360 |
Why?
|
| Testosterone | 10 | 2019 | 2491 | 0.350 |
Why?
|
| Vitamin E | 19 | 2009 | 874 | 0.350 |
Why?
|
| Mothers | 11 | 2022 | 2209 | 0.350 |
Why?
|
| Wet Macular Degeneration | 3 | 2017 | 165 | 0.350 |
Why?
|
| Estradiol | 11 | 2019 | 1951 | 0.350 |
Why?
|
| Sex Factors | 46 | 2019 | 10632 | 0.350 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 6 | 2014 | 416 | 0.350 |
Why?
|
| Telomere | 5 | 2019 | 943 | 0.340 |
Why?
|
| Motor Activity | 9 | 2018 | 2711 | 0.340 |
Why?
|
| Carbon | 5 | 2019 | 672 | 0.340 |
Why?
|
| Serine Endopeptidases | 3 | 2016 | 1027 | 0.330 |
Why?
|
| Young Adult | 57 | 2024 | 60066 | 0.330 |
Why?
|
| Aldosterone | 4 | 2025 | 881 | 0.330 |
Why?
|
| Body Height | 19 | 2020 | 1565 | 0.330 |
Why?
|
| Linear Models | 20 | 2020 | 5884 | 0.330 |
Why?
|
| Demography | 6 | 2023 | 1641 | 0.330 |
Why?
|
| Complement C2 | 5 | 2016 | 45 | 0.330 |
Why?
|
| Alcoholic Beverages | 8 | 2023 | 266 | 0.320 |
Why?
|
| Phenotype | 17 | 2025 | 16726 | 0.320 |
Why?
|
| Complement Factor B | 5 | 2016 | 57 | 0.320 |
Why?
|
| Vehicle Emissions | 4 | 2008 | 651 | 0.320 |
Why?
|
| C-Reactive Protein | 6 | 2019 | 3858 | 0.310 |
Why?
|
| Overweight | 8 | 2025 | 2448 | 0.310 |
Why?
|
| Nutritional Physiological Phenomena | 7 | 2017 | 360 | 0.310 |
Why?
|
| Metabolomics | 6 | 2024 | 1674 | 0.310 |
Why?
|
| Environmental Exposure | 5 | 2023 | 4543 | 0.310 |
Why?
|
| Multiple Myeloma | 8 | 2022 | 5196 | 0.310 |
Why?
|
| Fatty Acids | 10 | 2022 | 1812 | 0.310 |
Why?
|
| Delirium | 4 | 2023 | 1696 | 0.310 |
Why?
|
| Age of Onset | 8 | 2020 | 3346 | 0.300 |
Why?
|
| Apolipoprotein C-III | 2 | 2021 | 210 | 0.300 |
Why?
|
| Video Games | 3 | 2016 | 202 | 0.300 |
Why?
|
| Carbonated Beverages | 4 | 2021 | 210 | 0.300 |
Why?
|
| Choroidal Neovascularization | 3 | 2018 | 364 | 0.300 |
Why?
|
| Food, Fortified | 3 | 2020 | 189 | 0.290 |
Why?
|
| Television | 3 | 2016 | 410 | 0.290 |
Why?
|
| Lens, Crystalline | 5 | 2022 | 387 | 0.290 |
Why?
|
| Tobacco Use Disorder | 2 | 2011 | 708 | 0.290 |
Why?
|
| Gestational Age | 4 | 2022 | 3621 | 0.290 |
Why?
|
| Tea | 3 | 2021 | 289 | 0.290 |
Why?
|
| Cognition Disorders | 9 | 2016 | 3980 | 0.290 |
Why?
|
| Progestins | 8 | 2021 | 302 | 0.280 |
Why?
|
| Insulin Resistance | 4 | 2022 | 3986 | 0.280 |
Why?
|
| Depression | 7 | 2024 | 8230 | 0.280 |
Why?
|
| CA-125 Antigen | 2 | 2019 | 281 | 0.280 |
Why?
|
| Leukocytes | 5 | 2018 | 2034 | 0.280 |
Why?
|
| Early Detection of Cancer | 7 | 2024 | 3239 | 0.270 |
Why?
|
| Population Surveillance | 12 | 2019 | 2596 | 0.270 |
Why?
|
| Scotoma | 3 | 2021 | 128 | 0.270 |
Why?
|
| Vitamin B 12 | 5 | 2019 | 529 | 0.270 |
Why?
|
| Mass Screening | 13 | 2024 | 5458 | 0.270 |
Why?
|
| Xanthophylls | 7 | 2013 | 95 | 0.270 |
Why?
|
| Carcinoma, Lobular | 1 | 2010 | 480 | 0.270 |
Why?
|
| Disease Management | 1 | 2017 | 2535 | 0.260 |
Why?
|
| Calcium, Dietary | 7 | 2017 | 533 | 0.260 |
Why?
|
| Health Status | 5 | 2019 | 4091 | 0.260 |
Why?
|
| Predictive Value of Tests | 21 | 2020 | 15453 | 0.260 |
Why?
|
| Aging | 28 | 2019 | 8743 | 0.260 |
Why?
|
| Prevalence | 23 | 2019 | 15869 | 0.260 |
Why?
|
| Milk | 3 | 2018 | 438 | 0.260 |
Why?
|
| Biomedical Research | 4 | 2019 | 3463 | 0.260 |
Why?
|
| Lipoproteins, HDL | 6 | 2021 | 682 | 0.260 |
Why?
|
| Receptor, erbB-2 | 7 | 2019 | 2603 | 0.260 |
Why?
|
| Weight Loss | 7 | 2019 | 2721 | 0.250 |
Why?
|
| Starch | 2 | 2016 | 81 | 0.250 |
Why?
|
| Lung Diseases, Obstructive | 9 | 1998 | 311 | 0.250 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 2010 | 1099 | 0.250 |
Why?
|
| DNA | 4 | 2016 | 7213 | 0.250 |
Why?
|
| Otitis Media with Effusion | 4 | 2000 | 115 | 0.250 |
Why?
|
| Therapeutics | 1 | 2006 | 113 | 0.250 |
Why?
|
| Cholesterol, HDL | 14 | 2022 | 1820 | 0.250 |
Why?
|
| Estrogens, Conjugated (USP) | 3 | 2017 | 277 | 0.250 |
Why?
|
| Periodontitis | 2 | 2021 | 577 | 0.250 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2008 | 309 | 0.250 |
Why?
|
| Cross-Sectional Studies | 38 | 2024 | 26379 | 0.250 |
Why?
|
| Hormones | 3 | 2018 | 866 | 0.250 |
Why?
|
| Vitamin B 6 | 4 | 2013 | 237 | 0.250 |
Why?
|
| Adult Children | 2 | 2019 | 104 | 0.240 |
Why?
|
| Sciatica | 2 | 2002 | 97 | 0.240 |
Why?
|
| Porphyria, Hepatoerythropoietic | 2 | 2002 | 8 | 0.240 |
Why?
|
| Isoflavones | 2 | 2016 | 139 | 0.240 |
Why?
|
| Ocular Hypertension | 2 | 2022 | 211 | 0.240 |
Why?
|
| Analgesics | 6 | 2018 | 1071 | 0.240 |
Why?
|
| Counseling | 3 | 2012 | 1554 | 0.240 |
Why?
|
| Anovulation | 4 | 2009 | 54 | 0.240 |
Why?
|
| Prostatitis | 2 | 2015 | 102 | 0.240 |
Why?
|
| Glaucoma | 3 | 2022 | 1194 | 0.240 |
Why?
|
| Hypertrophy, Left Ventricular | 2 | 2021 | 856 | 0.240 |
Why?
|
| Triglycerides | 16 | 2022 | 2464 | 0.240 |
Why?
|
| Menstrual Cycle | 4 | 2019 | 546 | 0.240 |
Why?
|
| Photosensitivity Disorders | 2 | 2002 | 79 | 0.230 |
Why?
|
| Cognition | 9 | 2019 | 7073 | 0.230 |
Why?
|
| Estrogen Receptor alpha | 3 | 2018 | 581 | 0.230 |
Why?
|
| Family | 8 | 2012 | 3209 | 0.230 |
Why?
|
| Principal Component Analysis | 3 | 2023 | 948 | 0.230 |
Why?
|
| Estrone | 5 | 2018 | 234 | 0.230 |
Why?
|
| Genetic Variation | 7 | 2020 | 6610 | 0.230 |
Why?
|
| Lipids | 7 | 2019 | 3345 | 0.230 |
Why?
|
| Phobic Disorders | 2 | 2018 | 441 | 0.230 |
Why?
|
| Pets | 1 | 2024 | 47 | 0.230 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 4 | 2019 | 276 | 0.230 |
Why?
|
| Health Behavior | 4 | 2017 | 2650 | 0.230 |
Why?
|
| Ethanol | 10 | 2023 | 1331 | 0.230 |
Why?
|
| Erythrocyte Membrane | 4 | 2020 | 438 | 0.230 |
Why?
|
| Analysis of Variance | 28 | 2004 | 6229 | 0.220 |
Why?
|
| Transportation | 2 | 2020 | 217 | 0.220 |
Why?
|
| Circadian Rhythm | 4 | 2024 | 2593 | 0.220 |
Why?
|
| Salmonella Food Poisoning | 2 | 2014 | 11 | 0.220 |
Why?
|
| Cholesterol | 21 | 2020 | 2914 | 0.220 |
Why?
|
| Age Distribution | 9 | 2018 | 2873 | 0.220 |
Why?
|
| Minerals | 2 | 2016 | 282 | 0.220 |
Why?
|
| Sodium, Dietary | 3 | 2020 | 426 | 0.220 |
Why?
|
| Seasons | 3 | 2018 | 1524 | 0.220 |
Why?
|
| Epidemiologic Studies | 4 | 2023 | 677 | 0.220 |
Why?
|
| Adenoma | 7 | 2016 | 2159 | 0.220 |
Why?
|
| Fatty Acids, Monounsaturated | 4 | 2022 | 190 | 0.220 |
Why?
|
| Statistics as Topic | 15 | 2018 | 2357 | 0.220 |
Why?
|
| Genetic Association Studies | 3 | 2015 | 2744 | 0.210 |
Why?
|
| Cysteine | 4 | 2019 | 897 | 0.210 |
Why?
|
| Hormone Replacement Therapy | 4 | 2009 | 757 | 0.210 |
Why?
|
| Metabolic Networks and Pathways | 3 | 2019 | 800 | 0.210 |
Why?
|
| Diet, Carbohydrate-Restricted | 2 | 2023 | 263 | 0.210 |
Why?
|
| H-Reflex | 3 | 2017 | 25 | 0.210 |
Why?
|
| Hair Dyes | 3 | 2020 | 30 | 0.210 |
Why?
|
| Decision Support Techniques | 1 | 2013 | 2008 | 0.210 |
Why?
|
| Risk Reduction Behavior | 6 | 2021 | 1119 | 0.210 |
Why?
|
| Infant, Newborn | 30 | 2022 | 26421 | 0.210 |
Why?
|
| Telemedicine | 1 | 2020 | 3109 | 0.210 |
Why?
|
| Mental Recall | 7 | 2021 | 1226 | 0.210 |
Why?
|
| Pubic Symphysis | 1 | 2022 | 21 | 0.210 |
Why?
|
| Uveitis, Anterior | 1 | 2023 | 103 | 0.210 |
Why?
|
| Docosahexaenoic Acids | 7 | 2017 | 914 | 0.210 |
Why?
|
| Polymorphism, Genetic | 5 | 2008 | 4249 | 0.200 |
Why?
|
| Pelvic Pain | 2 | 2015 | 300 | 0.200 |
Why?
|
| Double-Blind Method | 29 | 2018 | 12466 | 0.200 |
Why?
|
| Blood Glucose | 12 | 2020 | 6431 | 0.200 |
Why?
|
| Prenatal Exposure Delayed Effects | 5 | 2022 | 2539 | 0.200 |
Why?
|
| Receptors, Androgen | 3 | 2019 | 1089 | 0.200 |
Why?
|
| gamma-Tocopherol | 1 | 2022 | 29 | 0.200 |
Why?
|
| Mouth Neoplasms | 4 | 2010 | 597 | 0.200 |
Why?
|
| Occupational Diseases | 5 | 2006 | 1457 | 0.200 |
Why?
|
| Infant | 25 | 2022 | 36535 | 0.200 |
Why?
|
| Severity of Illness Index | 9 | 2020 | 15949 | 0.200 |
Why?
|
| Dehydroepiandrosterone Sulfate | 4 | 2019 | 241 | 0.200 |
Why?
|
| Cortisone | 1 | 2022 | 90 | 0.200 |
Why?
|
| Chromatography, Liquid | 5 | 2023 | 996 | 0.200 |
Why?
|
| Tissue Array Analysis | 7 | 2021 | 551 | 0.200 |
Why?
|
| Diethylstilbestrol | 1 | 2022 | 85 | 0.200 |
Why?
|
| Amino Acids, Branched-Chain | 2 | 2021 | 267 | 0.190 |
Why?
|
| Occupational Exposure | 3 | 2008 | 1807 | 0.190 |
Why?
|
| Homocysteine | 4 | 2019 | 637 | 0.190 |
Why?
|
| Neoplasms | 28 | 2023 | 22371 | 0.190 |
Why?
|
| Acrylamide | 2 | 2013 | 59 | 0.190 |
Why?
|
| Complement System Proteins | 2 | 2018 | 738 | 0.190 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2003 | 203 | 0.190 |
Why?
|
| Registries | 10 | 2024 | 8375 | 0.190 |
Why?
|
| Eye Proteins | 3 | 2018 | 628 | 0.190 |
Why?
|
| Patient Compliance | 10 | 2018 | 2697 | 0.190 |
Why?
|
| Mortality | 11 | 2019 | 2911 | 0.190 |
Why?
|
| Prader-Willi Syndrome | 2 | 1999 | 81 | 0.190 |
Why?
|
| Sex Hormone-Binding Globulin | 5 | 2019 | 553 | 0.190 |
Why?
|
| Body Composition | 5 | 2015 | 2462 | 0.190 |
Why?
|
| Diet, Vegetarian | 3 | 2021 | 181 | 0.190 |
Why?
|
| Taste | 1 | 2002 | 190 | 0.190 |
Why?
|
| Health Promotion | 4 | 2020 | 2210 | 0.180 |
Why?
|
| Cataract Extraction | 8 | 2002 | 464 | 0.180 |
Why?
|
| Pyridoxal Phosphate | 2 | 2019 | 123 | 0.180 |
Why?
|
| Seafood | 4 | 2019 | 395 | 0.180 |
Why?
|
| Europe | 6 | 2020 | 3436 | 0.180 |
Why?
|
| Systole | 11 | 2019 | 937 | 0.180 |
Why?
|
| Renin-Angiotensin System | 2 | 2025 | 737 | 0.180 |
Why?
|
| Dose-Response Relationship, Drug | 19 | 2018 | 10763 | 0.180 |
Why?
|
| Electrodiagnosis | 2 | 2017 | 149 | 0.180 |
Why?
|
| Tandem Mass Spectrometry | 6 | 2023 | 1197 | 0.180 |
Why?
|
| Drinking Behavior | 1 | 2021 | 103 | 0.180 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2020 | 3251 | 0.180 |
Why?
|
| Asthma | 14 | 2015 | 6291 | 0.180 |
Why?
|
| Relief Work | 1 | 2022 | 131 | 0.180 |
Why?
|
| Dietary Fats, Unsaturated | 6 | 2007 | 223 | 0.180 |
Why?
|
| Respiratory Tract Diseases | 6 | 2010 | 744 | 0.180 |
Why?
|
| Williams Syndrome | 2 | 2001 | 195 | 0.170 |
Why?
|
| Family Health | 6 | 2011 | 1255 | 0.170 |
Why?
|
| Pregnancy Complications | 7 | 2024 | 2973 | 0.170 |
Why?
|
| Pregnancy Complications, Cardiovascular | 3 | 2020 | 519 | 0.170 |
Why?
|
| Cyclooxygenase 2 | 2 | 2022 | 598 | 0.170 |
Why?
|
| Sodium Chloride | 1 | 2002 | 584 | 0.170 |
Why?
|
| Occupational Health | 3 | 2020 | 812 | 0.170 |
Why?
|
| Diagnostic Techniques, Obstetrical and Gynecological | 1 | 2020 | 30 | 0.170 |
Why?
|
| Rhodopsin | 7 | 2008 | 198 | 0.170 |
Why?
|
| Pseudouridine | 1 | 2020 | 19 | 0.170 |
Why?
|
| Calibration | 2 | 2022 | 819 | 0.170 |
Why?
|
| Ownership | 1 | 2022 | 338 | 0.170 |
Why?
|
| Melatonin | 3 | 2019 | 670 | 0.170 |
Why?
|
| Pregnancy Outcome | 4 | 2024 | 2972 | 0.170 |
Why?
|
| Anxiety | 4 | 2024 | 4672 | 0.170 |
Why?
|
| Myocardial Infarction | 31 | 2021 | 11519 | 0.170 |
Why?
|
| Colonic Polyps | 2 | 2023 | 557 | 0.170 |
Why?
|
| Occult Blood | 1 | 2001 | 199 | 0.170 |
Why?
|
| Prostatic Neoplasms | 7 | 2021 | 11101 | 0.170 |
Why?
|
| Hyperinsulinism | 1 | 2022 | 402 | 0.170 |
Why?
|
| Uterus | 2 | 2022 | 663 | 0.170 |
Why?
|
| Urinary Tract Infections | 5 | 1989 | 804 | 0.170 |
Why?
|
| Maternal Age | 9 | 2006 | 805 | 0.170 |
Why?
|
| Tobacco Smoke Pollution | 6 | 2011 | 828 | 0.170 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2022 | 269 | 0.160 |
Why?
|
| Plant Oils | 4 | 2023 | 199 | 0.160 |
Why?
|
| Nutritive Value | 3 | 2019 | 351 | 0.160 |
Why?
|
| Child, Preschool | 46 | 2022 | 42669 | 0.160 |
Why?
|
| Uveitis | 1 | 2023 | 398 | 0.160 |
Why?
|
| Reference Values | 10 | 2018 | 4939 | 0.160 |
Why?
|
| Cerebrovascular Disorders | 14 | 1999 | 1485 | 0.160 |
Why?
|
| Thromboembolism | 2 | 2005 | 1004 | 0.160 |
Why?
|
| Hip Fractures | 3 | 2018 | 997 | 0.160 |
Why?
|
| Hyperlipidemias | 2 | 2019 | 772 | 0.160 |
Why?
|
| Osteoarthritis, Hip | 1 | 2023 | 409 | 0.160 |
Why?
|
| Hypercholesterolemia | 5 | 2019 | 1145 | 0.160 |
Why?
|
| Urinary Incontinence | 3 | 2008 | 490 | 0.160 |
Why?
|
| Nutrition Policy | 3 | 2016 | 467 | 0.160 |
Why?
|
| Behavior Therapy | 3 | 2014 | 886 | 0.160 |
Why?
|
| Models, Genetic | 2 | 2008 | 3447 | 0.160 |
Why?
|
| Caveolin 1 | 1 | 2020 | 255 | 0.160 |
Why?
|
| Flour | 1 | 2018 | 22 | 0.150 |
Why?
|
| Cyclooxygenase 1 | 1 | 2018 | 98 | 0.150 |
Why?
|
| alpha-Linolenic Acid | 2 | 2017 | 144 | 0.150 |
Why?
|
| Forced Expiratory Volume | 16 | 2002 | 1831 | 0.150 |
Why?
|
| Probability | 7 | 2021 | 2479 | 0.150 |
Why?
|
| Chronobiology Disorders | 1 | 2019 | 73 | 0.150 |
Why?
|
| Personality Development | 1 | 1999 | 241 | 0.150 |
Why?
|
| Anticarcinogenic Agents | 3 | 2014 | 251 | 0.150 |
Why?
|
| Oils | 1 | 2018 | 54 | 0.150 |
Why?
|
| Triticum | 1 | 2018 | 92 | 0.150 |
Why?
|
| Acetaminophen | 7 | 2012 | 552 | 0.150 |
Why?
|
| Phenylhydrazines | 1 | 2018 | 28 | 0.150 |
Why?
|
| Boston | 29 | 2019 | 9374 | 0.150 |
Why?
|
| Magnesium | 8 | 2016 | 816 | 0.150 |
Why?
|
| Potassium | 7 | 2016 | 1315 | 0.150 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 2 | 2019 | 348 | 0.150 |
Why?
|
| Deficiency Diseases | 1 | 2018 | 74 | 0.150 |
Why?
|
| Carcinoma, Endometrioid | 3 | 2016 | 275 | 0.150 |
Why?
|
| Succinimides | 1 | 2018 | 83 | 0.150 |
Why?
|
| Depressive Disorder | 4 | 2019 | 3721 | 0.150 |
Why?
|
| Catheters, Indwelling | 5 | 1989 | 436 | 0.150 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2018 | 108 | 0.150 |
Why?
|
| Skin Neoplasms | 9 | 2020 | 5863 | 0.150 |
Why?
|
| Indenes | 1 | 2018 | 59 | 0.150 |
Why?
|
| Proxy | 1 | 2019 | 150 | 0.150 |
Why?
|
| Adrenal Glands | 1 | 2020 | 557 | 0.150 |
Why?
|
| Adenocarcinoma, Clear Cell | 2 | 2016 | 218 | 0.140 |
Why?
|
| Polymerase Chain Reaction | 3 | 2019 | 6082 | 0.140 |
Why?
|
| Stroke | 9 | 2019 | 9755 | 0.140 |
Why?
|
| Diabetes Mellitus, Type 1 | 5 | 2006 | 3447 | 0.140 |
Why?
|
| Cerebellar Neoplasms | 1 | 2022 | 591 | 0.140 |
Why?
|
| Markov Chains | 2 | 2012 | 979 | 0.140 |
Why?
|
| Diastole | 8 | 2000 | 785 | 0.140 |
Why?
|
| Dyslipidemias | 2 | 2020 | 873 | 0.140 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2011 | 706 | 0.140 |
Why?
|
| Ovary | 6 | 2019 | 965 | 0.140 |
Why?
|
| Adenocarcinoma | 4 | 2013 | 6395 | 0.140 |
Why?
|
| Trichomonas Infections | 1 | 2017 | 41 | 0.140 |
Why?
|
| Randomized Controlled Trials as Topic | 7 | 2006 | 10397 | 0.140 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2016 | 1613 | 0.140 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2022 | 498 | 0.140 |
Why?
|
| Interleukin-6 | 4 | 2019 | 3229 | 0.140 |
Why?
|
| Cross Infection | 6 | 1989 | 1425 | 0.140 |
Why?
|
| Hydrocortisone | 7 | 2019 | 1841 | 0.140 |
Why?
|
| Medulloblastoma | 1 | 2022 | 683 | 0.140 |
Why?
|
| Lung Neoplasms | 10 | 2020 | 13586 | 0.140 |
Why?
|
| Asymptomatic Diseases | 1 | 2020 | 590 | 0.140 |
Why?
|
| Hearing Loss | 1 | 2024 | 785 | 0.140 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2008 | 505 | 0.140 |
Why?
|
| Food Preferences | 3 | 2018 | 398 | 0.140 |
Why?
|
| Calcium | 6 | 2017 | 5792 | 0.140 |
Why?
|
| Medroxyprogesterone Acetate | 1 | 2017 | 155 | 0.140 |
Why?
|
| Femoral Neck Fractures | 1 | 2018 | 143 | 0.140 |
Why?
|
| Musculoskeletal System | 1 | 2019 | 188 | 0.140 |
Why?
|
| Retinal Cone Photoreceptor Cells | 1 | 2018 | 183 | 0.140 |
Why?
|
| Somatotypes | 1 | 2016 | 39 | 0.130 |
Why?
|
| DNA-Binding Proteins | 1 | 2014 | 9617 | 0.130 |
Why?
|
| Dinoprostone | 1 | 2019 | 597 | 0.130 |
Why?
|
| beta-Carotene 15,15'-Monooxygenase | 2 | 2013 | 12 | 0.130 |
Why?
|
| Reproduction | 5 | 2019 | 646 | 0.130 |
Why?
|
| Soy Foods | 1 | 2016 | 44 | 0.130 |
Why?
|
| Cholesterol, LDL | 13 | 2022 | 2403 | 0.130 |
Why?
|
| Rectal Neoplasms | 4 | 2017 | 1183 | 0.130 |
Why?
|
| Stress, Psychological | 5 | 2019 | 4530 | 0.130 |
Why?
|
| Pregnancy, Animal | 1 | 2016 | 124 | 0.130 |
Why?
|
| Colonoscopy | 5 | 2023 | 1409 | 0.130 |
Why?
|
| Metformin | 1 | 2024 | 909 | 0.130 |
Why?
|
| Blood Specimen Collection | 2 | 2017 | 238 | 0.130 |
Why?
|
| Voice Disorders | 1 | 2019 | 286 | 0.130 |
Why?
|
| Adipose Tissue | 8 | 2021 | 3334 | 0.130 |
Why?
|
| Twins | 4 | 2010 | 341 | 0.130 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2022 | 1040 | 0.130 |
Why?
|
| Venous Thrombosis | 1 | 2005 | 1321 | 0.130 |
Why?
|
| Milk, Human | 1 | 2020 | 490 | 0.130 |
Why?
|
| Electrolytes | 1 | 2016 | 279 | 0.130 |
Why?
|
| Emigrants and Immigrants | 1 | 2022 | 550 | 0.130 |
Why?
|
| Ceramides | 1 | 2017 | 203 | 0.130 |
Why?
|
| Otitis Media | 4 | 1997 | 288 | 0.130 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2016 | 124 | 0.130 |
Why?
|
| Fish Oils | 3 | 2013 | 483 | 0.120 |
Why?
|
| Semen Analysis | 1 | 2017 | 236 | 0.120 |
Why?
|
| Clinical Trials as Topic | 15 | 2013 | 8052 | 0.120 |
Why?
|
| Nonsteroidal Anti-Androgens | 1 | 2015 | 9 | 0.120 |
Why?
|
| Socioeconomic Factors | 11 | 2019 | 7852 | 0.120 |
Why?
|
| Personnel Staffing and Scheduling | 3 | 2016 | 497 | 0.120 |
Why?
|
| Platinum | 1 | 2016 | 222 | 0.120 |
Why?
|
| Sleep Deprivation | 3 | 2023 | 848 | 0.120 |
Why?
|
| Treatment Outcome | 21 | 2020 | 65379 | 0.120 |
Why?
|
| Self Care | 2 | 2012 | 799 | 0.120 |
Why?
|
| Sex Distribution | 4 | 2018 | 2278 | 0.120 |
Why?
|
| Nitrates | 2 | 2016 | 260 | 0.120 |
Why?
|
| Gene Expression | 5 | 2016 | 7601 | 0.120 |
Why?
|
| Citrullus | 1 | 2014 | 4 | 0.120 |
Why?
|
| Micronutrients | 4 | 2021 | 390 | 0.120 |
Why?
|
| Eicosapentaenoic Acid | 2 | 2017 | 565 | 0.120 |
Why?
|
| Phosphatidylethanolamines | 4 | 2022 | 131 | 0.120 |
Why?
|
| Retrospective Studies | 34 | 2023 | 81760 | 0.120 |
Why?
|
| Keloid | 1 | 2015 | 55 | 0.120 |
Why?
|
| Beverages | 5 | 2021 | 819 | 0.120 |
Why?
|
| Sensitivity and Specificity | 10 | 2020 | 14729 | 0.120 |
Why?
|
| Epidemiology | 1 | 1997 | 278 | 0.120 |
Why?
|
| Matrix Metalloproteinase 7 | 1 | 2014 | 60 | 0.120 |
Why?
|
| Motivation | 2 | 2008 | 2020 | 0.120 |
Why?
|
| Urinalysis | 1 | 2016 | 370 | 0.120 |
Why?
|
| Infertility, Male | 1 | 2017 | 397 | 0.120 |
Why?
|
| Twins, Dizygotic | 4 | 2006 | 236 | 0.120 |
Why?
|
| Phenols | 2 | 2016 | 526 | 0.120 |
Why?
|
| Hypoglycemic Agents | 2 | 2024 | 3109 | 0.120 |
Why?
|
| Disease-Free Survival | 2 | 2022 | 6847 | 0.110 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2014 | 147 | 0.110 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 1 | 2016 | 195 | 0.110 |
Why?
|
| Thinness | 1 | 2017 | 483 | 0.110 |
Why?
|
| Lens Cortex, Crystalline | 1 | 1993 | 21 | 0.110 |
Why?
|
| Carbohydrates | 2 | 2020 | 389 | 0.110 |
Why?
|
| Lens Nucleus, Crystalline | 1 | 1993 | 32 | 0.110 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2014 | 139 | 0.110 |
Why?
|
| Alleles | 5 | 2020 | 6894 | 0.110 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2018 | 878 | 0.110 |
Why?
|
| Salmonella | 1 | 2014 | 125 | 0.110 |
Why?
|
| Models, Economic | 1 | 2018 | 719 | 0.110 |
Why?
|
| Sigmoidoscopy | 2 | 2013 | 150 | 0.110 |
Why?
|
| Myoblasts, Skeletal | 1 | 2014 | 74 | 0.110 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2015 | 1886 | 0.110 |
Why?
|
| Fovea Centralis | 1 | 2014 | 126 | 0.110 |
Why?
|
| Air Pollutants | 3 | 2023 | 2916 | 0.110 |
Why?
|
| Terminal Repeat Sequences | 1 | 2013 | 70 | 0.110 |
Why?
|
| Renin | 3 | 2025 | 648 | 0.110 |
Why?
|
| Aldehyde Dehydrogenase | 2 | 2024 | 146 | 0.110 |
Why?
|
| Spine | 1 | 2020 | 1140 | 0.110 |
Why?
|
| Adiponectin | 2 | 2018 | 1117 | 0.110 |
Why?
|
| Blindness | 2 | 2015 | 587 | 0.110 |
Why?
|
| Gene Expression Profiling | 4 | 2024 | 9540 | 0.110 |
Why?
|
| Refugees | 1 | 2022 | 615 | 0.110 |
Why?
|
| Disease Outbreaks | 2 | 2014 | 1761 | 0.110 |
Why?
|
| Lovastatin | 1 | 1993 | 115 | 0.110 |
Why?
|
| Peripheral Vascular Diseases | 3 | 2003 | 489 | 0.110 |
Why?
|
| Coronary Artery Disease | 7 | 2018 | 6568 | 0.110 |
Why?
|
| Photography | 5 | 2020 | 537 | 0.110 |
Why?
|
| Growth Differentiation Factors | 1 | 2014 | 99 | 0.110 |
Why?
|
| Receptors, Somatostatin | 1 | 2014 | 138 | 0.110 |
Why?
|
| Urinary Catheterization | 3 | 1983 | 195 | 0.110 |
Why?
|
| 4-Butyrolactone | 1 | 2013 | 60 | 0.110 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2016 | 553 | 0.110 |
Why?
|
| Glioma | 3 | 2019 | 3503 | 0.110 |
Why?
|
| Endophenotypes | 1 | 2015 | 259 | 0.110 |
Why?
|
| Mastocytosis, Systemic | 1 | 2014 | 102 | 0.110 |
Why?
|
| Epidemics | 1 | 2019 | 517 | 0.110 |
Why?
|
| Administration, Oral | 5 | 2018 | 4034 | 0.110 |
Why?
|
| Physical Conditioning, Animal | 1 | 2016 | 363 | 0.110 |
Why?
|
| DNA, Neoplasm | 3 | 2013 | 1744 | 0.100 |
Why?
|
| Geriatric Assessment | 1 | 2020 | 1422 | 0.100 |
Why?
|
| Massachusetts | 16 | 2008 | 8890 | 0.100 |
Why?
|
| Complement C1 | 1 | 2012 | 31 | 0.100 |
Why?
|
| Digoxin | 1 | 2014 | 246 | 0.100 |
Why?
|
| Rejuvenation | 1 | 2014 | 110 | 0.100 |
Why?
|
| Neonatal Screening | 1 | 2017 | 619 | 0.100 |
Why?
|
| Contraceptives, Oral, Hormonal | 3 | 2007 | 190 | 0.100 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2015 | 462 | 0.100 |
Why?
|
| Physicians | 5 | 2018 | 4598 | 0.100 |
Why?
|
| Speech | 2 | 1990 | 557 | 0.100 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2023 | 1417 | 0.100 |
Why?
|
| Normal Distribution | 1 | 1993 | 272 | 0.100 |
Why?
|
| Imidazoles | 3 | 2003 | 1169 | 0.100 |
Why?
|
| Software | 2 | 2017 | 4480 | 0.100 |
Why?
|
| Ultraviolet Rays | 2 | 2020 | 1103 | 0.100 |
Why?
|
| Lignans | 1 | 2013 | 84 | 0.100 |
Why?
|
| Progesterone | 1 | 2017 | 752 | 0.100 |
Why?
|
| Infant, Premature | 3 | 2020 | 2123 | 0.100 |
Why?
|
| Sweetening Agents | 3 | 2021 | 290 | 0.100 |
Why?
|
| Pathology, Molecular | 1 | 2015 | 329 | 0.100 |
Why?
|
| Spinal Fractures | 1 | 2019 | 710 | 0.100 |
Why?
|
| Gastroenteritis | 1 | 2014 | 235 | 0.100 |
Why?
|
| Optic Atrophy | 1 | 2013 | 79 | 0.100 |
Why?
|
| Metabolic Diseases | 1 | 2019 | 684 | 0.100 |
Why?
|
| Linkage Disequilibrium | 1 | 2017 | 1997 | 0.100 |
Why?
|
| Fatigue | 2 | 2018 | 1557 | 0.100 |
Why?
|
| Tonometry, Ocular | 3 | 2019 | 238 | 0.100 |
Why?
|
| Poverty | 4 | 2019 | 2720 | 0.100 |
Why?
|
| Fallopian Tubes | 1 | 2013 | 179 | 0.100 |
Why?
|
| Patients | 1 | 2019 | 908 | 0.100 |
Why?
|
| Oral Health | 2 | 2016 | 493 | 0.100 |
Why?
|
| Recreation | 2 | 2024 | 124 | 0.100 |
Why?
|
| Attention | 5 | 2016 | 2423 | 0.100 |
Why?
|
| Herpesviridae Infections | 1 | 2013 | 269 | 0.100 |
Why?
|
| Iodine | 1 | 2014 | 285 | 0.100 |
Why?
|
| Phenacetin | 7 | 1991 | 14 | 0.100 |
Why?
|
| Actigraphy | 1 | 2016 | 527 | 0.100 |
Why?
|
| Sodium Chloride, Dietary | 2 | 2025 | 301 | 0.100 |
Why?
|
| Patient Education as Topic | 1 | 2022 | 2337 | 0.100 |
Why?
|
| Postpartum Period | 3 | 2019 | 1197 | 0.100 |
Why?
|
| Absorptiometry, Photon | 2 | 2015 | 1758 | 0.100 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2022 | 1437 | 0.100 |
Why?
|
| Herpesvirus 8, Human | 1 | 2013 | 256 | 0.100 |
Why?
|
| Radiography | 5 | 2018 | 6986 | 0.100 |
Why?
|
| Physical Examination | 1 | 2018 | 1263 | 0.100 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 1993 | 330 | 0.100 |
Why?
|
| Diabetes Mellitus | 7 | 2022 | 5891 | 0.100 |
Why?
|
| Preoperative Care | 1 | 2020 | 2258 | 0.100 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2024 | 9419 | 0.090 |
Why?
|
| Models, Cardiovascular | 2 | 2001 | 981 | 0.090 |
Why?
|
| Peptides, Cyclic | 1 | 2013 | 391 | 0.090 |
Why?
|
| Optical Devices | 1 | 2011 | 35 | 0.090 |
Why?
|
| Arthritis, Rheumatoid | 5 | 2013 | 3781 | 0.090 |
Why?
|
| Alopecia | 1 | 2016 | 416 | 0.090 |
Why?
|
| Carotid Artery Diseases | 1 | 2018 | 879 | 0.090 |
Why?
|
| Nuclear Family | 2 | 2008 | 311 | 0.090 |
Why?
|
| Tooth Loss | 2 | 2003 | 200 | 0.090 |
Why?
|
| DNA Methylation | 4 | 2018 | 4428 | 0.090 |
Why?
|
| Mathematical Computing | 4 | 2004 | 142 | 0.090 |
Why?
|
| Survival Rate | 6 | 2023 | 12840 | 0.090 |
Why?
|
| Walking | 4 | 2024 | 1201 | 0.090 |
Why?
|
| Optic Disk Drusen | 1 | 2011 | 38 | 0.090 |
Why?
|
| Carcinoma, Basal Cell | 4 | 2020 | 565 | 0.090 |
Why?
|
| Obesity, Abdominal | 1 | 2014 | 375 | 0.090 |
Why?
|
| Molecular Typing | 1 | 2011 | 115 | 0.090 |
Why?
|
| Psychometrics | 1 | 2020 | 3063 | 0.090 |
Why?
|
| Blood Pressure Monitors | 1 | 1990 | 33 | 0.090 |
Why?
|
| Gene Frequency | 2 | 2018 | 3623 | 0.090 |
Why?
|
| 25-Hydroxyvitamin D 2 | 1 | 2010 | 40 | 0.090 |
Why?
|
| Community Health Centers | 2 | 2013 | 469 | 0.090 |
Why?
|
| Acute Kidney Injury | 1 | 2023 | 1942 | 0.090 |
Why?
|
| Homosexuality, Female | 1 | 2012 | 171 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2014 | 725 | 0.090 |
Why?
|
| Social Support | 2 | 2019 | 2193 | 0.090 |
Why?
|
| Sleep | 6 | 2024 | 4818 | 0.090 |
Why?
|
| Biopsy | 5 | 2024 | 6792 | 0.090 |
Why?
|
| Respiration | 4 | 1995 | 1665 | 0.090 |
Why?
|
| Sodium | 6 | 2024 | 1597 | 0.090 |
Why?
|
| False Positive Reactions | 1 | 2013 | 963 | 0.090 |
Why?
|
| California | 2 | 2013 | 1438 | 0.090 |
Why?
|
| Bisexuality | 1 | 2012 | 295 | 0.090 |
Why?
|
| Sunlight | 3 | 2002 | 337 | 0.090 |
Why?
|
| Prenatal Diagnosis | 1 | 2017 | 1275 | 0.090 |
Why?
|
| Macular Edema | 1 | 2014 | 387 | 0.090 |
Why?
|
| Premature Birth | 1 | 2022 | 1829 | 0.090 |
Why?
|
| Brain Neoplasms | 4 | 2022 | 9118 | 0.090 |
Why?
|
| Disease | 1 | 2015 | 675 | 0.090 |
Why?
|
| Fallopian Tube Neoplasms | 1 | 2013 | 329 | 0.090 |
Why?
|
| Drug Administration Schedule | 2 | 2018 | 4861 | 0.090 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2015 | 577 | 0.090 |
Why?
|
| Inflammation Mediators | 1 | 2019 | 1892 | 0.080 |
Why?
|
| Aortic Valve | 1 | 2020 | 1970 | 0.080 |
Why?
|
| Lung | 12 | 2015 | 10101 | 0.080 |
Why?
|
| Physical Exertion | 5 | 2008 | 668 | 0.080 |
Why?
|
| Folic Acid Deficiency | 1 | 2010 | 117 | 0.080 |
Why?
|
| Developing Countries | 1 | 2022 | 2910 | 0.080 |
Why?
|
| Family Characteristics | 4 | 2019 | 1003 | 0.080 |
Why?
|
| Calcifediol | 1 | 2010 | 160 | 0.080 |
Why?
|
| Benzhydryl Compounds | 1 | 2016 | 944 | 0.080 |
Why?
|
| Behavior Control | 1 | 2009 | 46 | 0.080 |
Why?
|
| Precancerous Conditions | 2 | 2007 | 985 | 0.080 |
Why?
|
| Myopia | 1 | 2012 | 254 | 0.080 |
Why?
|
| C-Peptide | 1 | 2011 | 443 | 0.080 |
Why?
|
| Nevus | 3 | 2005 | 205 | 0.080 |
Why?
|
| Air Pollution | 1 | 2023 | 2374 | 0.080 |
Why?
|
| Body Weights and Measures | 1 | 2010 | 208 | 0.080 |
Why?
|
| Trace Elements | 3 | 1996 | 193 | 0.080 |
Why?
|
| Antigens, Viral | 1 | 2013 | 995 | 0.080 |
Why?
|
| Osteoporotic Fractures | 1 | 2014 | 417 | 0.080 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2020 | 1566 | 0.080 |
Why?
|
| Lighting | 1 | 2011 | 210 | 0.080 |
Why?
|
| Complement Pathway, Alternative | 1 | 2009 | 113 | 0.080 |
Why?
|
| Image Processing, Computer-Assisted | 6 | 2018 | 9016 | 0.080 |
Why?
|
| Genome, Bacterial | 1 | 2014 | 796 | 0.080 |
Why?
|
| Substance-Related Disorders | 5 | 2024 | 4423 | 0.080 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2020 | 2145 | 0.080 |
Why?
|
| Recovery of Function | 1 | 2019 | 2981 | 0.080 |
Why?
|
| Glycemic Index | 3 | 2020 | 400 | 0.080 |
Why?
|
| Bariatric Surgery | 1 | 2019 | 1001 | 0.080 |
Why?
|
| Memory, Short-Term | 1 | 2015 | 1007 | 0.080 |
Why?
|
| Neuropsychological Tests | 4 | 2016 | 7140 | 0.080 |
Why?
|
| Regeneration | 2 | 2016 | 1524 | 0.080 |
Why?
|
| Nails | 3 | 1996 | 298 | 0.080 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2023 | 2298 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2020 | 3517 | 0.080 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2014 | 846 | 0.080 |
Why?
|
| Bronchial Hyperreactivity | 3 | 1995 | 301 | 0.080 |
Why?
|
| Antibodies, Neoplasm | 1 | 2010 | 283 | 0.080 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2010 | 208 | 0.080 |
Why?
|
| Neoplasm Staging | 7 | 2020 | 11244 | 0.080 |
Why?
|
| Reproductive Behavior | 1 | 2008 | 27 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2024 | 8648 | 0.080 |
Why?
|
| Behavior | 2 | 2011 | 542 | 0.080 |
Why?
|
| Critical Illness | 2 | 2018 | 2755 | 0.080 |
Why?
|
| Emergency Medicine | 1 | 2018 | 1223 | 0.080 |
Why?
|
| Bronchial Provocation Tests | 6 | 1995 | 216 | 0.080 |
Why?
|
| Mongolia | 2 | 2018 | 93 | 0.080 |
Why?
|
| Quality of Life | 3 | 2019 | 13490 | 0.080 |
Why?
|
| Plasmids | 1 | 2013 | 2269 | 0.080 |
Why?
|
| Streptococcus agalactiae | 4 | 1998 | 337 | 0.080 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2011 | 384 | 0.080 |
Why?
|
| Anticonvulsants | 1 | 2018 | 1923 | 0.080 |
Why?
|
| Arylamine N-Acetyltransferase | 1 | 2008 | 87 | 0.080 |
Why?
|
| Talc | 1 | 2008 | 48 | 0.080 |
Why?
|
| HLA Antigens | 1 | 2013 | 1334 | 0.070 |
Why?
|
| NF-kappa B | 1 | 2016 | 2494 | 0.070 |
Why?
|
| Abdomen | 5 | 2005 | 1136 | 0.070 |
Why?
|
| Valproic Acid | 1 | 2010 | 444 | 0.070 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2011 | 567 | 0.070 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2020 | 4058 | 0.070 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2011 | 395 | 0.070 |
Why?
|
| Brain Ischemia | 3 | 2019 | 3007 | 0.070 |
Why?
|
| Bronchitis | 7 | 1998 | 194 | 0.070 |
Why?
|
| Syndrome | 4 | 2015 | 3273 | 0.070 |
Why?
|
| Dihydroxycholecalciferols | 1 | 2007 | 17 | 0.070 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2009 | 332 | 0.070 |
Why?
|
| Human Growth Hormone | 1 | 2012 | 651 | 0.070 |
Why?
|
| Adolescent Development | 1 | 2011 | 276 | 0.070 |
Why?
|
| Dermatology | 1 | 2017 | 905 | 0.070 |
Why?
|
| Genes, Recessive | 4 | 2008 | 625 | 0.070 |
Why?
|
| Apolipoproteins E | 2 | 2012 | 1461 | 0.070 |
Why?
|
| Quality Assurance, Health Care | 1 | 2017 | 2176 | 0.070 |
Why?
|
| Contrast Sensitivity | 3 | 1993 | 253 | 0.070 |
Why?
|
| Mast Cells | 1 | 2014 | 1406 | 0.070 |
Why?
|
| Energy Metabolism | 4 | 2015 | 2907 | 0.070 |
Why?
|
| Data Collection | 2 | 2023 | 3326 | 0.070 |
Why?
|
| Interdisciplinary Communication | 1 | 2013 | 937 | 0.070 |
Why?
|
| Epitopes | 1 | 2013 | 2527 | 0.070 |
Why?
|
| Echocardiography | 4 | 2021 | 5047 | 0.070 |
Why?
|
| Lipoproteins | 5 | 1996 | 880 | 0.070 |
Why?
|
| Comorbidity | 6 | 2019 | 10590 | 0.070 |
Why?
|
| Immunohistochemistry | 5 | 2023 | 11095 | 0.070 |
Why?
|
| Diterpenes | 3 | 2018 | 170 | 0.070 |
Why?
|
| Hemoglobins | 1 | 2013 | 1531 | 0.070 |
Why?
|
| Genital Diseases, Female | 4 | 2019 | 192 | 0.070 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2007 | 131 | 0.070 |
Why?
|
| Anthocyanins | 2 | 2020 | 80 | 0.070 |
Why?
|
| Public Health | 2 | 2018 | 2679 | 0.070 |
Why?
|
| Molecular Epidemiology | 1 | 2008 | 473 | 0.070 |
Why?
|
| Zinc | 3 | 2008 | 677 | 0.070 |
Why?
|
| Sexual Behavior | 8 | 2014 | 2197 | 0.070 |
Why?
|
| DNA Replication | 1 | 2013 | 1427 | 0.070 |
Why?
|
| Glutathione Transferase | 1 | 2008 | 564 | 0.070 |
Why?
|
| Population Dynamics | 1 | 2008 | 314 | 0.070 |
Why?
|
| Vulnerable Populations | 1 | 2012 | 718 | 0.070 |
Why?
|
| Maternal Exposure | 2 | 2017 | 1096 | 0.070 |
Why?
|
| Needlestick Injuries | 1 | 2006 | 71 | 0.070 |
Why?
|
| Databases, Factual | 4 | 2020 | 8080 | 0.070 |
Why?
|
| Trans-Activators | 1 | 2016 | 2857 | 0.070 |
Why?
|
| Fatty Acids, Unsaturated | 5 | 2009 | 542 | 0.070 |
Why?
|
| Receptors, Cell Surface | 1 | 2015 | 2819 | 0.060 |
Why?
|
| Exudates and Transudates | 1 | 2006 | 175 | 0.060 |
Why?
|
| Neoplasm Proteins | 1 | 2018 | 3604 | 0.060 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2013 | 1854 | 0.060 |
Why?
|
| Wounds and Injuries | 1 | 2019 | 2517 | 0.060 |
Why?
|
| Learning | 1 | 2015 | 1759 | 0.060 |
Why?
|
| Flavones | 2 | 2020 | 66 | 0.060 |
Why?
|
| Vital Capacity | 10 | 2002 | 996 | 0.060 |
Why?
|
| Diet, Atherogenic | 1 | 2005 | 92 | 0.060 |
Why?
|
| Introns | 1 | 2008 | 965 | 0.060 |
Why?
|
| Cell Division | 5 | 1985 | 4477 | 0.060 |
Why?
|
| Dark Adaptation | 4 | 2003 | 224 | 0.060 |
Why?
|
| Hospitalization | 3 | 2024 | 10840 | 0.060 |
Why?
|
| Methacholine Chloride | 4 | 1994 | 220 | 0.060 |
Why?
|
| Leukoplakia, Oral | 1 | 2006 | 79 | 0.060 |
Why?
|
| Genome-Wide Association Study | 4 | 2019 | 12795 | 0.060 |
Why?
|
| Androgens | 2 | 2010 | 1281 | 0.060 |
Why?
|
| Germ-Line Mutation | 1 | 2014 | 1885 | 0.060 |
Why?
|
| Fishes | 3 | 2009 | 606 | 0.060 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2015 | 2057 | 0.060 |
Why?
|
| Leucine | 2 | 2021 | 547 | 0.060 |
Why?
|
| Mathematics | 3 | 2015 | 704 | 0.060 |
Why?
|
| Evidence-Based Medicine | 2 | 2016 | 3706 | 0.060 |
Why?
|
| Lymphoma | 1 | 2014 | 1898 | 0.060 |
Why?
|
| Mucin-1 | 1 | 2010 | 537 | 0.060 |
Why?
|
| Skin | 2 | 2015 | 4505 | 0.060 |
Why?
|
| Caregivers | 1 | 2018 | 2302 | 0.060 |
Why?
|
| Epigenomics | 1 | 2011 | 960 | 0.060 |
Why?
|
| Intelligence | 1 | 1990 | 926 | 0.060 |
Why?
|
| Controlled Clinical Trials as Topic | 2 | 2003 | 187 | 0.060 |
Why?
|
| Naphazoline | 1 | 1984 | 7 | 0.060 |
Why?
|
| Antipsychotic Agents | 1 | 2018 | 3081 | 0.060 |
Why?
|
| Animals | 24 | 2024 | 169285 | 0.060 |
Why?
|
| Vitamin D-Binding Protein | 2 | 2018 | 130 | 0.060 |
Why?
|
| Calcium Channel Blockers | 2 | 1998 | 687 | 0.060 |
Why?
|
| Fibrinopeptide A | 1 | 2004 | 43 | 0.060 |
Why?
|
| Nursing | 1 | 2004 | 35 | 0.060 |
Why?
|
| Patient Selection | 3 | 2013 | 4260 | 0.060 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2011 | 1367 | 0.060 |
Why?
|
| Educational Status | 3 | 1999 | 2515 | 0.060 |
Why?
|
| Accidents, Occupational | 1 | 2006 | 251 | 0.060 |
Why?
|
| Florida | 4 | 2024 | 417 | 0.060 |
Why?
|
| Flow Cytometry | 2 | 2014 | 5902 | 0.060 |
Why?
|
| Autoantibodies | 1 | 2013 | 2121 | 0.060 |
Why?
|
| Estriol | 1 | 1984 | 53 | 0.060 |
Why?
|
| Plasmalogens | 2 | 2022 | 30 | 0.060 |
Why?
|
| Lacerations | 1 | 2006 | 150 | 0.060 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 3490 | 0.060 |
Why?
|
| Diet, Reducing | 2 | 2009 | 487 | 0.060 |
Why?
|
| Memory | 4 | 2016 | 2207 | 0.060 |
Why?
|
| Japan | 2 | 2022 | 1418 | 0.060 |
Why?
|
| Creatinine | 8 | 2022 | 1918 | 0.060 |
Why?
|
| Respiratory Function Tests | 5 | 2015 | 1695 | 0.060 |
Why?
|
| Food Services | 1 | 2008 | 209 | 0.060 |
Why?
|
| Photic Stimulation | 2 | 2018 | 1997 | 0.060 |
Why?
|
| Glucose Tolerance Test | 2 | 2021 | 1183 | 0.060 |
Why?
|
| Receptors, Glucocorticoid | 3 | 1981 | 309 | 0.060 |
Why?
|
| Random Allocation | 10 | 2013 | 2395 | 0.060 |
Why?
|
| Camping | 1 | 2003 | 13 | 0.060 |
Why?
|
| Prostate-Specific Antigen | 1 | 2014 | 2463 | 0.060 |
Why?
|
| Prothrombin | 1 | 2004 | 194 | 0.060 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2008 | 835 | 0.060 |
Why?
|
| Sleep Disorders, Circadian Rhythm | 1 | 2006 | 197 | 0.060 |
Why?
|
| Histamine | 3 | 1995 | 496 | 0.060 |
Why?
|
| Dinoprost | 1 | 2004 | 139 | 0.060 |
Why?
|
| Patient Participation | 1 | 2013 | 1447 | 0.060 |
Why?
|
| Pain | 1 | 2019 | 5099 | 0.060 |
Why?
|
| Photoreceptor Cells | 3 | 1998 | 234 | 0.060 |
Why?
|
| Wound Healing | 1 | 2015 | 2815 | 0.060 |
Why?
|
| Respiratory Sounds | 3 | 1993 | 702 | 0.060 |
Why?
|
| Audiometry, Pure-Tone | 1 | 2024 | 210 | 0.050 |
Why?
|
| Antigens, Surface | 2 | 1998 | 1617 | 0.050 |
Why?
|
| Nuclear Proteins | 2 | 2020 | 5804 | 0.050 |
Why?
|
| Asialoglycoprotein Receptor | 1 | 2023 | 36 | 0.050 |
Why?
|
| Audiometry | 1 | 2024 | 253 | 0.050 |
Why?
|
| Macrophages | 1 | 2018 | 5802 | 0.050 |
Why?
|
| Drug Therapy, Combination | 8 | 2010 | 6316 | 0.050 |
Why?
|
| Neovascularization, Pathologic | 1 | 2014 | 2631 | 0.050 |
Why?
|
| Receptors, Leptin | 2 | 2018 | 352 | 0.050 |
Why?
|
| Ozone | 2 | 1998 | 496 | 0.050 |
Why?
|
| Self Concept | 2 | 2007 | 1043 | 0.050 |
Why?
|
| Ophthalmic Solutions | 1 | 1984 | 312 | 0.050 |
Why?
|
| Pruritus | 1 | 2006 | 379 | 0.050 |
Why?
|
| Contraception | 3 | 2021 | 362 | 0.050 |
Why?
|
| Leptin | 1 | 2011 | 1599 | 0.050 |
Why?
|
| Language Development | 1 | 1984 | 183 | 0.050 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2022 | 1772 | 0.050 |
Why?
|
| Central Nervous System Stimulants | 1 | 2011 | 1168 | 0.050 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2007 | 386 | 0.050 |
Why?
|
| Aldehyde Reductase | 2 | 2000 | 70 | 0.050 |
Why?
|
| Disposable Equipment | 1 | 2022 | 46 | 0.050 |
Why?
|
| Sucking Behavior | 1 | 2002 | 27 | 0.050 |
Why?
|
| Receptor, Insulin | 2 | 2018 | 839 | 0.050 |
Why?
|
| Epilepsy | 1 | 2018 | 3326 | 0.050 |
Why?
|
| Fragile X Syndrome | 1 | 2004 | 116 | 0.050 |
Why?
|
| Adolescent Behavior | 1 | 2011 | 1186 | 0.050 |
Why?
|
| Tamoxifen | 1 | 2007 | 966 | 0.050 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2011 | 3252 | 0.050 |
Why?
|
| Exons | 1 | 2008 | 2394 | 0.050 |
Why?
|
| Inflammation | 2 | 2021 | 10873 | 0.050 |
Why?
|
| Brazil | 2 | 2018 | 1250 | 0.050 |
Why?
|
| Saliva | 2 | 2019 | 853 | 0.050 |
Why?
|
| Receptors, Calcitriol | 2 | 2016 | 361 | 0.050 |
Why?
|
| Acute Disease | 5 | 2023 | 7243 | 0.050 |
Why?
|
| Lysophosphatidylcholines | 1 | 2022 | 77 | 0.050 |
Why?
|
| Parents | 4 | 2010 | 3595 | 0.050 |
Why?
|
| Tunica Intima | 1 | 2004 | 459 | 0.050 |
Why?
|
| Norgestrel | 1 | 2021 | 11 | 0.050 |
Why?
|
| Desogestrel | 1 | 2021 | 18 | 0.050 |
Why?
|
| Postoperative Complications | 4 | 2023 | 15833 | 0.050 |
Why?
|
| Lung Volume Measurements | 2 | 1980 | 381 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2019 | 7876 | 0.050 |
Why?
|
| Ocular Physiological Phenomena | 1 | 1982 | 67 | 0.050 |
Why?
|
| Retinal Detachment | 1 | 2006 | 429 | 0.050 |
Why?
|
| Medical Records | 5 | 2003 | 1410 | 0.050 |
Why?
|
| Ion Channel Gating | 1 | 2004 | 429 | 0.050 |
Why?
|
| Follicular Atresia | 1 | 2021 | 7 | 0.050 |
Why?
|
| Thrombin | 1 | 2004 | 600 | 0.050 |
Why?
|
| Sensory Thresholds | 1 | 2003 | 377 | 0.050 |
Why?
|
| Choice Behavior | 1 | 2008 | 848 | 0.050 |
Why?
|
| Melanoma | 5 | 2005 | 5706 | 0.050 |
Why?
|
| Cholesterol, Dietary | 5 | 2003 | 224 | 0.050 |
Why?
|
| Bone Resorption | 2 | 2002 | 728 | 0.050 |
Why?
|
| Child Abuse, Sexual | 1 | 2024 | 400 | 0.050 |
Why?
|
| Biological Clocks | 1 | 2024 | 321 | 0.050 |
Why?
|
| Psychology | 2 | 2018 | 353 | 0.050 |
Why?
|
| Internship and Residency | 3 | 2006 | 5953 | 0.050 |
Why?
|
| Isoleucine | 1 | 2021 | 111 | 0.050 |
Why?
|
| Child Behavior Disorders | 2 | 2004 | 812 | 0.050 |
Why?
|
| Urban Population | 3 | 2019 | 2046 | 0.050 |
Why?
|
| Antihypertensive Agents | 2 | 1991 | 2029 | 0.050 |
Why?
|
| Levonorgestrel | 1 | 2021 | 80 | 0.050 |
Why?
|
| Object Attachment | 1 | 2024 | 326 | 0.050 |
Why?
|
| Sulfisoxazole | 1 | 2000 | 8 | 0.050 |
Why?
|
| Bronchi | 3 | 2011 | 850 | 0.050 |
Why?
|
| Ethinyl Estradiol | 1 | 2021 | 114 | 0.050 |
Why?
|
| Child Development | 2 | 2011 | 2330 | 0.050 |
Why?
|
| Stem Cells | 2 | 2024 | 3538 | 0.050 |
Why?
|
| Health Education | 1 | 2008 | 1059 | 0.050 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2004 | 371 | 0.050 |
Why?
|
| Hypolipidemic Agents | 1 | 2005 | 609 | 0.050 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2004 | 540 | 0.050 |
Why?
|
| Recurrence | 7 | 2004 | 8509 | 0.050 |
Why?
|
| Blood Proteins | 2 | 1995 | 1191 | 0.050 |
Why?
|
| Contraceptives, Oral, Combined | 1 | 2021 | 118 | 0.050 |
Why?
|
| Language | 1 | 1990 | 1557 | 0.050 |
Why?
|
| Leisure Activities | 3 | 2015 | 310 | 0.050 |
Why?
|
| Vasoconstrictor Agents | 1 | 1984 | 656 | 0.050 |
Why?
|
| Mycoplasma Infections | 6 | 1987 | 120 | 0.050 |
Why?
|
| Germany | 2 | 2014 | 883 | 0.050 |
Why?
|
| Insulin | 3 | 2020 | 6610 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2011 | 3713 | 0.050 |
Why?
|
| Arteriosclerosis | 2 | 2003 | 1055 | 0.040 |
Why?
|
| Sexually Transmitted Diseases | 2 | 2024 | 668 | 0.040 |
Why?
|
| Paternal Age | 3 | 2006 | 87 | 0.040 |
Why?
|
| HSP110 Heat-Shock Proteins | 1 | 2020 | 10 | 0.040 |
Why?
|
| Infertility | 1 | 2007 | 655 | 0.040 |
Why?
|
| Neural Conduction | 1 | 2002 | 443 | 0.040 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-3 | 1 | 2020 | 34 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 10 | 1988 | 7477 | 0.040 |
Why?
|
| Receptors, Steroid | 1 | 1981 | 156 | 0.040 |
Why?
|
| Food, Organic | 2 | 2012 | 34 | 0.040 |
Why?
|
| Immunoassay | 2 | 2014 | 746 | 0.040 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 1 | 2000 | 45 | 0.040 |
Why?
|
| Chewing Gum | 1 | 2000 | 40 | 0.040 |
Why?
|
| Flavonols | 1 | 2020 | 85 | 0.040 |
Why?
|
| Carotid Arteries | 1 | 2004 | 942 | 0.040 |
Why?
|
| Bacteriuria | 6 | 1983 | 102 | 0.040 |
Why?
|
| Neural Inhibition | 1 | 2004 | 588 | 0.040 |
Why?
|
| Interleukin-8 | 1 | 2023 | 705 | 0.040 |
Why?
|
| Retinal Diseases | 2 | 2003 | 710 | 0.040 |
Why?
|
| Erythrocytes | 3 | 2020 | 2418 | 0.040 |
Why?
|
| Students | 2 | 2008 | 1744 | 0.040 |
Why?
|
| Administration, Inhalation | 2 | 2015 | 1169 | 0.040 |
Why?
|
| Form Perception | 1 | 2001 | 175 | 0.040 |
Why?
|
| Haplotypes | 3 | 2011 | 2722 | 0.040 |
Why?
|
| Habits | 1 | 2020 | 148 | 0.040 |
Why?
|
| Comparative Effectiveness Research | 2 | 2017 | 714 | 0.040 |
Why?
|
| China | 3 | 2015 | 2395 | 0.040 |
Why?
|
| Psychological Tests | 2 | 1999 | 643 | 0.040 |
Why?
|
| Amoxicillin | 1 | 2000 | 182 | 0.040 |
Why?
|
| alpha-Amylases | 1 | 2019 | 39 | 0.040 |
Why?
|
| Albumins | 1 | 2022 | 577 | 0.040 |
Why?
|
| Dexamethasone | 4 | 1985 | 1965 | 0.040 |
Why?
|
| Selenium | 3 | 1995 | 418 | 0.040 |
Why?
|
| Asbestosis | 1 | 1979 | 81 | 0.040 |
Why?
|
| Poisson Distribution | 1 | 2000 | 506 | 0.040 |
Why?
|
| Periodontal Diseases | 1 | 2003 | 455 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 5 | 2008 | 5536 | 0.040 |
Why?
|
| Proline | 2 | 1991 | 455 | 0.040 |
Why?
|
| Cathartics | 1 | 2000 | 129 | 0.040 |
Why?
|
| Accidents, Traffic | 1 | 2005 | 818 | 0.040 |
Why?
|
| Genetics, Behavioral | 1 | 1999 | 53 | 0.040 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2004 | 598 | 0.040 |
Why?
|
| Genomics | 1 | 2015 | 5926 | 0.040 |
Why?
|
| Steroids | 1 | 2004 | 938 | 0.040 |
Why?
|
| Office Visits | 2 | 2015 | 595 | 0.040 |
Why?
|
| Cell Survival | 2 | 1979 | 5789 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2014 | 4978 | 0.040 |
Why?
|
| Dogs | 1 | 2024 | 3845 | 0.040 |
Why?
|
| Workload | 1 | 2005 | 849 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2002 | 1587 | 0.040 |
Why?
|
| Time | 1 | 2020 | 552 | 0.040 |
Why?
|
| Defecation | 1 | 2000 | 191 | 0.040 |
Why?
|
| Intergenerational Relations | 1 | 2019 | 68 | 0.040 |
Why?
|
| Perceptual Disorders | 1 | 2001 | 199 | 0.040 |
Why?
|
| Asia | 1 | 2020 | 630 | 0.040 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 2019 | 133 | 0.040 |
Why?
|
| Glutathione Peroxidase | 1 | 2000 | 259 | 0.040 |
Why?
|
| Mother-Child Relations | 1 | 1982 | 498 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2011 | 4939 | 0.040 |
Why?
|
| Sweden | 2 | 2018 | 1382 | 0.040 |
Why?
|
| Cell Membrane | 2 | 2022 | 3655 | 0.040 |
Why?
|
| Medical Errors | 1 | 2006 | 1260 | 0.040 |
Why?
|
| Mycoplasma | 5 | 1986 | 146 | 0.040 |
Why?
|
| Neoplasms, Hormone-Dependent | 2 | 2015 | 410 | 0.040 |
Why?
|
| Riboflavin | 2 | 2016 | 107 | 0.040 |
Why?
|
| Administration, Cutaneous | 2 | 2018 | 716 | 0.040 |
Why?
|
| Heart Failure | 2 | 2022 | 11879 | 0.040 |
Why?
|
| Low Tension Glaucoma | 1 | 2018 | 24 | 0.040 |
Why?
|
| Medical History Taking | 4 | 1998 | 779 | 0.040 |
Why?
|
| Light | 1 | 2004 | 1355 | 0.040 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2022 | 905 | 0.040 |
Why?
|
| Personality | 1 | 2002 | 559 | 0.040 |
Why?
|
| Traction | 1 | 2018 | 112 | 0.040 |
Why?
|
| Trichomonas vaginalis | 2 | 2017 | 70 | 0.040 |
Why?
|
| Air Pollutants, Occupational | 2 | 1985 | 406 | 0.040 |
Why?
|
| Netherlands | 3 | 2009 | 2277 | 0.040 |
Why?
|
| Iron | 1 | 2006 | 1813 | 0.040 |
Why?
|
| Nursing Staff | 2 | 2015 | 113 | 0.040 |
Why?
|
| Pilot Projects | 4 | 2020 | 8741 | 0.040 |
Why?
|
| Puerto Rico | 2 | 2010 | 380 | 0.040 |
Why?
|
| Arteries | 1 | 2003 | 1127 | 0.040 |
Why?
|
| Anticholesteremic Agents | 2 | 1995 | 972 | 0.040 |
Why?
|
| Snoring | 1 | 1999 | 211 | 0.040 |
Why?
|
| Voice Quality | 1 | 2019 | 226 | 0.040 |
Why?
|
| Receptors, Adiponectin | 1 | 2018 | 82 | 0.040 |
Why?
|
| Bangladesh | 1 | 2020 | 742 | 0.040 |
Why?
|
| Oxidants, Photochemical | 1 | 1998 | 77 | 0.040 |
Why?
|
| Respiratory Mechanics | 1 | 2002 | 721 | 0.040 |
Why?
|
| Financial Management | 1 | 2019 | 161 | 0.040 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2020 | 409 | 0.040 |
Why?
|
| Heart Diseases | 2 | 2015 | 2819 | 0.040 |
Why?
|
| Menstruation | 4 | 2005 | 310 | 0.040 |
Why?
|
| Ureaplasma | 5 | 1987 | 59 | 0.040 |
Why?
|
| Food Analysis | 2 | 1990 | 103 | 0.040 |
Why?
|
| Asbestos | 1 | 1979 | 251 | 0.040 |
Why?
|
| Space Perception | 1 | 2001 | 466 | 0.040 |
Why?
|
| Primary Health Care | 2 | 2012 | 4746 | 0.040 |
Why?
|
| Hypnosis | 1 | 1978 | 84 | 0.040 |
Why?
|
| Follicular Phase | 1 | 2018 | 143 | 0.040 |
Why?
|
| Biological Specimen Banks | 1 | 2023 | 788 | 0.040 |
Why?
|
| Residence Characteristics | 2 | 2007 | 2118 | 0.040 |
Why?
|
| Luteal Phase | 1 | 2018 | 138 | 0.040 |
Why?
|
| Angiotensin II | 1 | 2020 | 844 | 0.040 |
Why?
|
| Climate | 1 | 2018 | 146 | 0.040 |
Why?
|
| Menstruation Disturbances | 1 | 2018 | 143 | 0.040 |
Why?
|
| Adenocarcinoma, Mucinous | 2 | 2013 | 525 | 0.040 |
Why?
|
| Mutation | 6 | 2013 | 30237 | 0.040 |
Why?
|
| Superoxide Dismutase | 1 | 2000 | 596 | 0.040 |
Why?
|
| Kidney Diseases | 8 | 1991 | 2100 | 0.040 |
Why?
|
| Sodium Salicylate | 1 | 2016 | 18 | 0.040 |
Why?
|
| Methylnitrosourea | 1 | 2016 | 30 | 0.040 |
Why?
|
| Collagen Type V | 1 | 2016 | 16 | 0.030 |
Why?
|
| Stroke Volume | 2 | 2022 | 5622 | 0.030 |
Why?
|
| Trauma Severity Indices | 1 | 2019 | 479 | 0.030 |
Why?
|
| Leukemia, Lymphoid | 1 | 2017 | 311 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p57 | 1 | 2016 | 43 | 0.030 |
Why?
|
| Chi-Square Distribution | 2 | 2008 | 3436 | 0.030 |
Why?
|
| Warfarin | 3 | 2004 | 1493 | 0.030 |
Why?
|
| Metabolome | 1 | 2024 | 1009 | 0.030 |
Why?
|
| Program Evaluation | 3 | 2014 | 2507 | 0.030 |
Why?
|
| Fertility | 2 | 1997 | 771 | 0.030 |
Why?
|
| Dipeptides | 1 | 2019 | 386 | 0.030 |
Why?
|
| Internet | 2 | 2019 | 3110 | 0.030 |
Why?
|
| Enalapril | 1 | 2018 | 317 | 0.030 |
Why?
|
| Drug Evaluation | 2 | 1991 | 642 | 0.030 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2022 | 1120 | 0.030 |
Why?
|
| Epithelium | 1 | 2021 | 1607 | 0.030 |
Why?
|
| Retinoid X Receptors | 1 | 2016 | 91 | 0.030 |
Why?
|
| Phlebotomy | 1 | 2017 | 138 | 0.030 |
Why?
|
| Carcinoma | 1 | 2008 | 2332 | 0.030 |
Why?
|
| Dermatoglyphics | 1 | 1976 | 21 | 0.030 |
Why?
|
| Staphylococcus aureus | 1 | 1984 | 1430 | 0.030 |
Why?
|
| Relaxation Therapy | 1 | 1978 | 181 | 0.030 |
Why?
|
| Sunburn | 3 | 2005 | 156 | 0.030 |
Why?
|
| Lead | 1 | 2002 | 882 | 0.030 |
Why?
|
| Rotation | 1 | 2018 | 517 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1998 | 781 | 0.030 |
Why?
|
| Alkylating Agents | 1 | 2016 | 132 | 0.030 |
Why?
|
| Oxidative Stress | 2 | 2015 | 3140 | 0.030 |
Why?
|
| Automation, Laboratory | 1 | 2016 | 102 | 0.030 |
Why?
|
| Multiple Sclerosis | 1 | 2011 | 3250 | 0.030 |
Why?
|
| Pedigree | 4 | 2019 | 4539 | 0.030 |
Why?
|
| Antibodies, Protozoan | 1 | 2017 | 251 | 0.030 |
Why?
|
| Point Mutation | 2 | 1998 | 1596 | 0.030 |
Why?
|
| Geography | 1 | 2018 | 652 | 0.030 |
Why?
|
| State Medicine | 1 | 2017 | 219 | 0.030 |
Why?
|
| Abdominal Fat | 1 | 2017 | 221 | 0.030 |
Why?
|
| Radioimmunoassay | 1 | 2016 | 863 | 0.030 |
Why?
|
| Blood Transfusion, Autologous | 1 | 1996 | 130 | 0.030 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2016 | 324 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2021 | 1337 | 0.030 |
Why?
|
| Spain | 1 | 2017 | 485 | 0.030 |
Why?
|
| Sulfates | 1 | 2016 | 379 | 0.030 |
Why?
|
| Hospitals, General | 5 | 1979 | 809 | 0.030 |
Why?
|
| Genistein | 1 | 2015 | 87 | 0.030 |
Why?
|
| Women's Health Services | 1 | 2016 | 87 | 0.030 |
Why?
|
| Thymine | 1 | 2015 | 69 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2004 | 2227 | 0.030 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2000 | 640 | 0.030 |
Why?
|
| Causality | 1 | 2022 | 1254 | 0.030 |
Why?
|
| Genetic Markers | 2 | 2012 | 2603 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2019 | 6525 | 0.030 |
Why?
|
| Substance Withdrawal Syndrome | 3 | 2000 | 628 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 2010 | 1535 | 0.030 |
Why?
|
| Diabetes Complications | 7 | 1999 | 1320 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2019 | 23648 | 0.030 |
Why?
|
| Frail Elderly | 1 | 2020 | 781 | 0.030 |
Why?
|
| Mexico | 1 | 2017 | 769 | 0.030 |
Why?
|
| Risk-Taking | 1 | 2020 | 1023 | 0.030 |
Why?
|
| Streptococcal Infections | 2 | 1998 | 619 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 2 | 2014 | 1737 | 0.030 |
Why?
|
| Thiamine | 1 | 2016 | 160 | 0.030 |
Why?
|
| Nicotine | 1 | 2000 | 680 | 0.030 |
Why?
|
| Muscle Development | 1 | 2016 | 258 | 0.030 |
Why?
|
| Coma | 1 | 2018 | 485 | 0.030 |
Why?
|
| Blood Flow Velocity | 1 | 2018 | 1375 | 0.030 |
Why?
|
| Vagina | 5 | 1986 | 850 | 0.030 |
Why?
|
| Bacterial Proteins | 2 | 1998 | 3840 | 0.030 |
Why?
|
| Infant, Low Birth Weight | 5 | 2004 | 871 | 0.030 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2014 | 142 | 0.030 |
Why?
|
| Cotinine | 1 | 1995 | 206 | 0.030 |
Why?
|
| Attitude to Health | 4 | 2008 | 2025 | 0.030 |
Why?
|
| Dementia | 1 | 2009 | 2740 | 0.030 |
Why?
|
| Cytosine | 1 | 2015 | 213 | 0.030 |
Why?
|
| Parabiosis | 1 | 2014 | 65 | 0.030 |
Why?
|
| Drug Utilization | 6 | 1996 | 1189 | 0.030 |
Why?
|
| Videodisc Recording | 1 | 2013 | 14 | 0.030 |
Why?
|
| Fractures, Bone | 3 | 2019 | 2062 | 0.030 |
Why?
|
| Pediatrics | 1 | 2009 | 3629 | 0.030 |
Why?
|
| Infant Formula | 1 | 2015 | 194 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2004 | 3728 | 0.030 |
Why?
|
| Feces | 1 | 2001 | 1511 | 0.030 |
Why?
|
| Food Handling | 1 | 2014 | 158 | 0.030 |
Why?
|
| Placebos | 3 | 1994 | 1667 | 0.030 |
Why?
|
| Bacteroides Infections | 1 | 1993 | 89 | 0.030 |
Why?
|
| Binomial Distribution | 1 | 1993 | 23 | 0.030 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2015 | 228 | 0.030 |
Why?
|
| Nephritis, Hereditary | 1 | 1974 | 78 | 0.030 |
Why?
|
| Nifedipine | 2 | 1984 | 220 | 0.030 |
Why?
|
| Intravitreal Injections | 1 | 2015 | 401 | 0.030 |
Why?
|
| Lost to Follow-Up | 1 | 2014 | 124 | 0.030 |
Why?
|
| Fasting | 3 | 2014 | 1610 | 0.030 |
Why?
|
| Laboratories | 1 | 2017 | 463 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 13677 | 0.030 |
Why?
|
| Margarine | 1 | 1993 | 17 | 0.030 |
Why?
|
| Coronary Angiography | 6 | 1995 | 4541 | 0.030 |
Why?
|
| DNA Helicases | 1 | 2019 | 854 | 0.030 |
Why?
|
| Meningitis, Meningococcal | 1 | 1973 | 43 | 0.030 |
Why?
|
| Stem Cell Niche | 1 | 2016 | 347 | 0.030 |
Why?
|
| Empirical Research | 1 | 2013 | 119 | 0.030 |
Why?
|
| Colorimetry | 1 | 1993 | 151 | 0.030 |
Why?
|
| Placental Hormones | 1 | 2012 | 11 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2019 | 1573 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2022 | 2885 | 0.030 |
Why?
|
| Atherectomy, Coronary | 1 | 1993 | 138 | 0.030 |
Why?
|
| Phosphates | 1 | 2016 | 765 | 0.030 |
Why?
|
| Mental Disorders | 2 | 2010 | 6873 | 0.030 |
Why?
|
| Consciousness Disorders | 1 | 1997 | 445 | 0.030 |
Why?
|
| Respiratory Tract Infections | 1 | 1980 | 1014 | 0.030 |
Why?
|
| Carcinoma, Acinar Cell | 1 | 2013 | 62 | 0.030 |
Why?
|
| Program Development | 1 | 2019 | 1300 | 0.030 |
Why?
|
| Epoxy Compounds | 1 | 2013 | 137 | 0.030 |
Why?
|
| Mosaicism | 1 | 1976 | 480 | 0.030 |
Why?
|
| Bacterial Capsules | 1 | 1993 | 247 | 0.030 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 1994 | 392 | 0.030 |
Why?
|
| Pyrus | 1 | 2012 | 13 | 0.030 |
Why?
|
| Emergency Medical Services | 1 | 2024 | 1947 | 0.030 |
Why?
|
| Coronary Circulation | 1 | 2018 | 1617 | 0.030 |
Why?
|
| Visual Field Tests | 2 | 2010 | 415 | 0.030 |
Why?
|
| Disability Evaluation | 1 | 2019 | 1835 | 0.030 |
Why?
|
| Interviews as Topic | 2 | 2010 | 2741 | 0.030 |
Why?
|
| Sports | 1 | 1998 | 703 | 0.030 |
Why?
|
| Visual Perception | 1 | 2001 | 1401 | 0.020 |
Why?
|
| Sp3 Transcription Factor | 1 | 2011 | 30 | 0.020 |
Why?
|
| Ohio | 2 | 2009 | 321 | 0.020 |
Why?
|
| Plant Extracts | 1 | 2016 | 499 | 0.020 |
Why?
|
| Videotape Recording | 1 | 2013 | 335 | 0.020 |
Why?
|
| Cells, Cultured | 3 | 2011 | 19025 | 0.020 |
Why?
|
| Republic of Korea | 1 | 2014 | 591 | 0.020 |
Why?
|
| Bacteroides fragilis | 1 | 1993 | 250 | 0.020 |
Why?
|
| Apolipoprotein A-II | 1 | 1992 | 41 | 0.020 |
Why?
|
| Observer Variation | 1 | 2018 | 2621 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2015 | 1703 | 0.020 |
Why?
|
| Keratin-6 | 1 | 2011 | 15 | 0.020 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2016 | 622 | 0.020 |
Why?
|
| Cross-Over Studies | 3 | 2005 | 2107 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2004 | 5151 | 0.020 |
Why?
|
| Molecular Sequence Data | 5 | 2013 | 17623 | 0.020 |
Why?
|
| Keratin-5 | 1 | 2011 | 43 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 2 | 2011 | 3620 | 0.020 |
Why?
|
| Malus | 1 | 2012 | 51 | 0.020 |
Why?
|
| DNA Damage | 1 | 2001 | 2469 | 0.020 |
Why?
|
| Particulate Matter | 1 | 2023 | 2617 | 0.020 |
Why?
|
| Phthalic Acids | 1 | 2016 | 487 | 0.020 |
Why?
|
| Weather | 1 | 2013 | 234 | 0.020 |
Why?
|
| Spirometry | 6 | 1998 | 929 | 0.020 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2013 | 300 | 0.020 |
Why?
|
| Cell Line | 5 | 2013 | 15602 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2011 | 294 | 0.020 |
Why?
|
| Forearm Injuries | 1 | 1991 | 68 | 0.020 |
Why?
|
| New England | 2 | 2013 | 1058 | 0.020 |
Why?
|
| New Hampshire | 2 | 2008 | 174 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2015 | 1743 | 0.020 |
Why?
|
| Urine | 4 | 1983 | 362 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2013 | 876 | 0.020 |
Why?
|
| Selection Bias | 2 | 2008 | 360 | 0.020 |
Why?
|
| Carbon Dioxide | 3 | 2006 | 1148 | 0.020 |
Why?
|
| Choline | 1 | 2013 | 522 | 0.020 |
Why?
|
| Meta-Analysis as Topic | 2 | 2013 | 1363 | 0.020 |
Why?
|
| Telephone | 2 | 2012 | 630 | 0.020 |
Why?
|
| Posture | 2 | 1986 | 957 | 0.020 |
Why?
|
| Ultrasonography | 3 | 2019 | 6004 | 0.020 |
Why?
|
| Functional Residual Capacity | 1 | 2010 | 70 | 0.020 |
Why?
|
| Kallikreins | 4 | 1987 | 219 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2011 | 378 | 0.020 |
Why?
|
| Bronchoconstriction | 1 | 1991 | 141 | 0.020 |
Why?
|
| Eligibility Determination | 1 | 1994 | 421 | 0.020 |
Why?
|
| Lymphoma, B-Cell | 1 | 2017 | 945 | 0.020 |
Why?
|
| Gastric Bypass | 1 | 2019 | 824 | 0.020 |
Why?
|
| Length of Stay | 3 | 2020 | 6498 | 0.020 |
Why?
|
| Women | 1 | 2012 | 225 | 0.020 |
Why?
|
| Apolipoprotein A-I | 1 | 1992 | 305 | 0.020 |
Why?
|
| Occupations | 1 | 1992 | 516 | 0.020 |
Why?
|
| Reaction Time | 1 | 2016 | 2101 | 0.020 |
Why?
|
| Histidine | 1 | 1991 | 301 | 0.020 |
Why?
|
| Electric Stimulation Therapy | 1 | 1996 | 635 | 0.020 |
Why?
|
| Multifactorial Inheritance | 1 | 2018 | 1422 | 0.020 |
Why?
|
| Cystadenocarcinoma | 1 | 2009 | 54 | 0.020 |
Why?
|
| Platelet Activation | 1 | 1993 | 644 | 0.020 |
Why?
|
| Models, Econometric | 1 | 2010 | 215 | 0.020 |
Why?
|
| Abscess | 1 | 1993 | 606 | 0.020 |
Why?
|
| Complement Factor I | 1 | 2009 | 14 | 0.020 |
Why?
|
| Contrast Media | 1 | 2023 | 5330 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 3948 | 0.020 |
Why?
|
| Toes | 3 | 1996 | 209 | 0.020 |
Why?
|
| Quality Indicators, Health Care | 1 | 2020 | 1805 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2016 | 1906 | 0.020 |
Why?
|
| Congenital Abnormalities | 3 | 1985 | 703 | 0.020 |
Why?
|
| Cold Temperature | 3 | 1989 | 791 | 0.020 |
Why?
|
| Mental Health | 1 | 2024 | 3275 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 2014 | 1864 | 0.020 |
Why?
|
| Microsatellite Instability | 1 | 2013 | 726 | 0.020 |
Why?
|
| Tablets | 1 | 2010 | 149 | 0.020 |
Why?
|
| Beer | 4 | 1993 | 135 | 0.020 |
Why?
|
| Running | 2 | 2008 | 490 | 0.020 |
Why?
|
| Developmental Disabilities | 1 | 1998 | 1518 | 0.020 |
Why?
|
| Information Systems | 1 | 2011 | 400 | 0.020 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 1999 | 1508 | 0.020 |
Why?
|
| Apigenin | 1 | 2009 | 16 | 0.020 |
Why?
|
| Preventive Health Services | 1 | 2014 | 570 | 0.020 |
Why?
|
| Child Nutrition Sciences | 1 | 2009 | 22 | 0.020 |
Why?
|
| Epidemiologic Research Design | 1 | 2013 | 368 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2022 | 3941 | 0.020 |
Why?
|
| Organ Size | 1 | 2014 | 2267 | 0.020 |
Why?
|
| Bottle Feeding | 1 | 1989 | 67 | 0.020 |
Why?
|
| Amino Acid Sequence | 3 | 2013 | 13422 | 0.020 |
Why?
|
| Budesonide | 1 | 2010 | 162 | 0.020 |
Why?
|
| Proteomics | 1 | 2023 | 3912 | 0.020 |
Why?
|
| Outpatients | 1 | 2017 | 1600 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2013 | 794 | 0.020 |
Why?
|
| Cyclosporins | 1 | 1989 | 216 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 1995 | 2596 | 0.020 |
Why?
|
| Erythromycin | 2 | 1987 | 115 | 0.020 |
Why?
|
| Codon | 1 | 1991 | 599 | 0.020 |
Why?
|
| Commerce | 1 | 2014 | 612 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2011 | 858 | 0.020 |
Why?
|
| Drug Prescriptions | 1 | 2018 | 1668 | 0.020 |
Why?
|
| Chlamydia Infections | 2 | 1985 | 365 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2016 | 2094 | 0.020 |
Why?
|
| Sex Characteristics | 3 | 2012 | 2649 | 0.020 |
Why?
|
| Bacteria | 1 | 1979 | 2216 | 0.020 |
Why?
|
| SEER Program | 1 | 2013 | 1444 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 1997 | 3403 | 0.020 |
Why?
|
| Respiration Disorders | 1 | 1991 | 364 | 0.020 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 1991 | 399 | 0.020 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2020 | 2195 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2016 | 3806 | 0.020 |
Why?
|
| Lactation | 1 | 1990 | 392 | 0.020 |
Why?
|
| Executive Function | 1 | 2016 | 1401 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2019 | 5315 | 0.020 |
Why?
|
| Monte Carlo Method | 1 | 1993 | 1259 | 0.020 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 1998 | 1243 | 0.020 |
Why?
|
| International Cooperation | 1 | 2014 | 1436 | 0.020 |
Why?
|
| Angina Pectoris | 3 | 1990 | 957 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2023 | 20762 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2009 | 3814 | 0.020 |
Why?
|
| Intrauterine Devices | 2 | 2007 | 115 | 0.020 |
Why?
|
| Alzheimer Disease | 1 | 2009 | 8759 | 0.020 |
Why?
|
| Utilization Review | 2 | 1979 | 381 | 0.020 |
Why?
|
| Puberty | 1 | 2011 | 501 | 0.020 |
Why?
|
| Equipment Contamination | 1 | 1989 | 183 | 0.020 |
Why?
|
| Down Syndrome | 1 | 1976 | 919 | 0.020 |
Why?
|
| Rural Population | 1 | 2018 | 2325 | 0.020 |
Why?
|
| Mycoplasmatales Infections | 1 | 1987 | 18 | 0.020 |
Why?
|
| Hair Preparations | 1 | 1987 | 33 | 0.020 |
Why?
|
| Health | 1 | 2010 | 398 | 0.020 |
Why?
|
| Serotonin | 1 | 1992 | 1043 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2018 | 4035 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2014 | 2414 | 0.020 |
Why?
|
| Death Certificates | 2 | 2004 | 172 | 0.020 |
Why?
|
| Schools, Medical | 1 | 1993 | 883 | 0.020 |
Why?
|
| Tyramine | 1 | 1966 | 55 | 0.020 |
Why?
|
| Reference Standards | 1 | 2010 | 1014 | 0.020 |
Why?
|
| Lipoproteins, VLDL | 3 | 1996 | 201 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 1999 | 13013 | 0.020 |
Why?
|
| Behavior, Addictive | 1 | 1992 | 428 | 0.020 |
Why?
|
| Drinking | 1 | 2007 | 196 | 0.020 |
Why?
|
| Universities | 3 | 2008 | 1005 | 0.020 |
Why?
|
| Lymphatic Metastasis | 2 | 2011 | 2914 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2011 | 1505 | 0.020 |
Why?
|
| Constriction, Pathologic | 3 | 1995 | 1104 | 0.020 |
Why?
|
| Radiography, Thoracic | 1 | 1993 | 1321 | 0.020 |
Why?
|
| Contraceptive Agents, Female | 1 | 2007 | 123 | 0.020 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 1993 | 1724 | 0.020 |
Why?
|
| Diabetic Angiopathies | 1 | 1991 | 806 | 0.020 |
Why?
|
| Monoamine Oxidase | 1 | 1966 | 180 | 0.020 |
Why?
|
| Prostatectomy | 1 | 2014 | 1786 | 0.020 |
Why?
|
| Mice | 6 | 2016 | 82049 | 0.020 |
Why?
|
| Genetic Linkage | 3 | 2004 | 2342 | 0.020 |
Why?
|
| Virus Replication | 1 | 2013 | 2458 | 0.020 |
Why?
|
| Cardiomegaly | 2 | 1985 | 591 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2013 | 1514 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 8142 | 0.020 |
Why?
|
| Family Planning Services | 1 | 2008 | 279 | 0.020 |
Why?
|
| Hematuria | 3 | 1978 | 232 | 0.020 |
Why?
|
| Nuclear Energy | 1 | 1985 | 15 | 0.020 |
Why?
|
| Fats, Unsaturated | 1 | 2005 | 21 | 0.020 |
Why?
|
| Corneal Transplantation | 1 | 1989 | 315 | 0.020 |
Why?
|
| Cephradine | 1 | 1984 | 4 | 0.020 |
Why?
|
| Moxalactam | 1 | 1984 | 9 | 0.020 |
Why?
|
| Cefonicid | 1 | 1984 | 7 | 0.020 |
Why?
|
| Cefamandole | 1 | 1984 | 9 | 0.020 |
Why?
|
| Cephalothin | 1 | 1984 | 28 | 0.020 |
Why?
|
| Microscopy, Electron | 2 | 1998 | 2560 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2018 | 3800 | 0.020 |
Why?
|
| Chlamydia | 1 | 1985 | 33 | 0.020 |
Why?
|
| Rats | 4 | 2016 | 23782 | 0.020 |
Why?
|
| Nafcillin | 1 | 1984 | 23 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 4 | 1996 | 1627 | 0.020 |
Why?
|
| Ships | 1 | 1985 | 53 | 0.010 |
Why?
|
| Linoleic Acid | 2 | 2001 | 158 | 0.010 |
Why?
|
| Jaundice, Neonatal | 1 | 1985 | 70 | 0.010 |
Why?
|
| Job Description | 1 | 2004 | 61 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 2010 | 1667 | 0.010 |
Why?
|
| Asia, Southeastern | 1 | 2004 | 115 | 0.010 |
Why?
|
| Androstenols | 1 | 2004 | 25 | 0.010 |
Why?
|
| New York City | 1 | 2007 | 737 | 0.010 |
Why?
|
| Methicillin | 1 | 1984 | 62 | 0.010 |
Why?
|
| Endometriosis | 1 | 2013 | 873 | 0.010 |
Why?
|
| Pigmentation | 1 | 2005 | 143 | 0.010 |
Why?
|
| Wine | 3 | 1993 | 172 | 0.010 |
Why?
|
| Chromosome Aberrations | 1 | 1991 | 1778 | 0.010 |
Why?
|
| Coal | 1 | 2004 | 122 | 0.010 |
Why?
|
| Guideline Adherence | 1 | 2014 | 2235 | 0.010 |
Why?
|
| Androstenedione | 1 | 2004 | 132 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2011 | 5028 | 0.010 |
Why?
|
| Language Tests | 1 | 1984 | 193 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2020 | 4858 | 0.010 |
Why?
|
| Pharmacogenetics | 1 | 2008 | 683 | 0.010 |
Why?
|
| Bone Density | 1 | 1997 | 3573 | 0.010 |
Why?
|
| PPAR gamma | 1 | 2007 | 487 | 0.010 |
Why?
|
| Color Perception Tests | 1 | 1983 | 12 | 0.010 |
Why?
|
| Genetics, Medical | 1 | 1986 | 334 | 0.010 |
Why?
|
| Proteinuria | 3 | 1978 | 611 | 0.010 |
Why?
|
| Kidney Neoplasms | 1 | 2020 | 4282 | 0.010 |
Why?
|
| Intracranial Thrombosis | 1 | 2004 | 107 | 0.010 |
Why?
|
| Ambulatory Care | 1 | 1994 | 2783 | 0.010 |
Why?
|
| Thyroid Hormones | 1 | 1966 | 407 | 0.010 |
Why?
|
| Lod Score | 1 | 2004 | 600 | 0.010 |
Why?
|
| Biological Availability | 1 | 2004 | 391 | 0.010 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2004 | 115 | 0.010 |
Why?
|
| Hair | 2 | 2005 | 508 | 0.010 |
Why?
|
| Fetal Growth Retardation | 1 | 2007 | 592 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2011 | 4620 | 0.010 |
Why?
|
| Angiotensinogen | 1 | 1984 | 161 | 0.010 |
Why?
|
| Color Vision Defects | 1 | 1983 | 28 | 0.010 |
Why?
|
| Angiotensins | 1 | 1984 | 141 | 0.010 |
Why?
|
| Candidiasis | 1 | 2006 | 367 | 0.010 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2007 | 572 | 0.010 |
Why?
|
| Dehydroepiandrosterone | 1 | 2004 | 259 | 0.010 |
Why?
|
| Neisseria meningitidis | 2 | 1993 | 111 | 0.010 |
Why?
|
| Retirement | 1 | 2004 | 198 | 0.010 |
Why?
|
| Drug Tolerance | 1 | 1984 | 365 | 0.010 |
Why?
|
| Atrial Fibrillation | 2 | 1992 | 5176 | 0.010 |
Why?
|
| Personnel, Hospital | 1 | 1985 | 285 | 0.010 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2004 | 225 | 0.010 |
Why?
|
| Structure-Activity Relationship | 3 | 1993 | 3056 | 0.010 |
Why?
|
| Fetal Heart | 1 | 1984 | 281 | 0.010 |
Why?
|
| Drug Combinations | 2 | 2007 | 2089 | 0.010 |
Why?
|
| Growth Substances | 1 | 1985 | 760 | 0.010 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2005 | 693 | 0.010 |
Why?
|
| International Normalized Ratio | 1 | 2004 | 382 | 0.010 |
Why?
|
| Maryland | 1 | 1983 | 278 | 0.010 |
Why?
|
| Heterozygote | 2 | 2007 | 2798 | 0.010 |
Why?
|
| Switzerland | 4 | 1991 | 323 | 0.010 |
Why?
|
| Diabetic Ketoacidosis | 1 | 2006 | 257 | 0.010 |
Why?
|
| Brain Infarction | 1 | 2004 | 286 | 0.010 |
Why?
|
| MicroRNAs | 1 | 2018 | 3803 | 0.010 |
Why?
|
| Blood Transfusion | 1 | 1989 | 1309 | 0.010 |
Why?
|
| Diet, Fat-Restricted | 1 | 2005 | 328 | 0.010 |
Why?
|
| Disease Models, Animal | 2 | 2016 | 18349 | 0.010 |
Why?
|
| Fibroblasts | 2 | 2011 | 4178 | 0.010 |
Why?
|
| Private Practice | 1 | 1983 | 154 | 0.010 |
Why?
|
| Accidents, Aviation | 1 | 1981 | 15 | 0.010 |
Why?
|
| Apoptosis | 2 | 2014 | 9527 | 0.010 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 1987 | 2185 | 0.010 |
Why?
|
| Ear, Middle | 1 | 1984 | 341 | 0.010 |
Why?
|
| Seat Belts | 1 | 1981 | 60 | 0.010 |
Why?
|
| Chromatin | 1 | 2013 | 2981 | 0.010 |
Why?
|
| Vision, Ocular | 1 | 1985 | 458 | 0.010 |
Why?
|
| Self Medication | 2 | 1981 | 115 | 0.010 |
Why?
|
| Electrocardiography | 3 | 1983 | 6412 | 0.010 |
Why?
|
| Pyridoxine | 1 | 1982 | 108 | 0.010 |
Why?
|
| Vitamin D Deficiency | 1 | 2011 | 1388 | 0.010 |
Why?
|
| Medicare | 1 | 2020 | 6809 | 0.010 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2005 | 1134 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2016 | 5341 | 0.010 |
Why?
|
| Specimen Handling | 2 | 2004 | 707 | 0.010 |
Why?
|
| Bundle-Branch Block | 1 | 1983 | 278 | 0.010 |
Why?
|
| Pennsylvania | 5 | 1979 | 615 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 7454 | 0.010 |
Why?
|
| Bulimia | 1 | 2003 | 405 | 0.010 |
Why?
|
| Stents | 1 | 1993 | 3197 | 0.010 |
Why?
|
| Wisconsin | 1 | 2001 | 122 | 0.010 |
Why?
|
| Employment | 1 | 1987 | 1110 | 0.010 |
Why?
|
| Puerperal Infection | 1 | 1980 | 46 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 2019 | 5367 | 0.010 |
Why?
|
| Morbidity | 1 | 1986 | 1755 | 0.010 |
Why?
|
| Fires | 1 | 1982 | 170 | 0.010 |
Why?
|
| Patella | 1 | 2002 | 317 | 0.010 |
Why?
|
| Antigens, Bacterial | 2 | 1998 | 1150 | 0.010 |
Why?
|
| Apolipoproteins | 2 | 1993 | 328 | 0.010 |
Why?
|
| Abortion, Induced | 2 | 1983 | 471 | 0.010 |
Why?
|
| Antibodies, Bacterial | 4 | 1981 | 1478 | 0.010 |
Why?
|
| Lipoprotein(a) | 1 | 2005 | 489 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2011 | 5797 | 0.010 |
Why?
|
| Neurologic Examination | 1 | 1983 | 914 | 0.010 |
Why?
|
| Aminoglycosides | 3 | 1988 | 161 | 0.010 |
Why?
|
| Hair Color | 2 | 1991 | 131 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 2 | 1984 | 1967 | 0.010 |
Why?
|
| Daucus carota | 1 | 1999 | 11 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1984 | 2486 | 0.010 |
Why?
|
| Upper Extremity | 1 | 2005 | 683 | 0.010 |
Why?
|
| Electronic Health Records | 1 | 2017 | 4887 | 0.010 |
Why?
|
| Angina, Unstable | 1 | 1984 | 893 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2011 | 3474 | 0.010 |
Why?
|
| Intelligence Tests | 1 | 2001 | 504 | 0.010 |
Why?
|
| Primary Prevention | 1 | 2007 | 1188 | 0.010 |
Why?
|
| Automobile Driving | 1 | 2005 | 442 | 0.010 |
Why?
|
| Sports Medicine | 2 | 1979 | 239 | 0.010 |
Why?
|
| Acoustic Stimulation | 1 | 2004 | 1255 | 0.010 |
Why?
|
| Pulmonary Diffusing Capacity | 1 | 1979 | 93 | 0.010 |
Why?
|
| Fundus Oculi | 2 | 1991 | 560 | 0.010 |
Why?
|
| Choroid | 1 | 1982 | 364 | 0.010 |
Why?
|
| Alcohol Oxidoreductases | 2 | 1977 | 164 | 0.010 |
Why?
|
| Obstetric Labor, Premature | 1 | 1981 | 268 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 7951 | 0.010 |
Why?
|
| Urethritis | 1 | 1978 | 30 | 0.010 |
Why?
|
| Retinaldehyde | 1 | 1998 | 24 | 0.010 |
Why?
|
| Lipoproteins, LDL | 3 | 1991 | 644 | 0.010 |
Why?
|
| Canada | 1 | 2004 | 2130 | 0.010 |
Why?
|
| Polymyxins | 1 | 1978 | 17 | 0.010 |
Why?
|
| Uterine Cervical Diseases | 1 | 1979 | 75 | 0.010 |
Why?
|
| Respiratory Hypersensitivity | 1 | 1980 | 272 | 0.010 |
Why?
|
| Lethal Dose 50 | 1 | 1998 | 71 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2003 | 1419 | 0.010 |
Why?
|
| Specific Gravity | 4 | 1983 | 18 | 0.010 |
Why?
|
| Neomycin | 1 | 1978 | 94 | 0.010 |
Why?
|
| Lidocaine | 1 | 2002 | 546 | 0.010 |
Why?
|
| Fluorescein Angiography | 2 | 2000 | 1086 | 0.010 |
Why?
|
| Operating Rooms | 1 | 1985 | 790 | 0.010 |
Why?
|
| X Chromosome | 3 | 1992 | 819 | 0.010 |
Why?
|
| Kidney Concentrating Ability | 2 | 1975 | 34 | 0.010 |
Why?
|
| Graft Survival | 1 | 1989 | 3887 | 0.010 |
Why?
|
| Marital Status | 1 | 1999 | 426 | 0.010 |
Why?
|
| Least-Squares Analysis | 1 | 1999 | 367 | 0.010 |
Why?
|
| Cosmetics | 1 | 1979 | 104 | 0.010 |
Why?
|
| Gardnerella vaginalis | 1 | 1977 | 20 | 0.010 |
Why?
|
| Haemophilus | 1 | 1977 | 28 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2014 | 10478 | 0.010 |
Why?
|
| Arginine | 1 | 1982 | 932 | 0.010 |
Why?
|
| Urogenital Neoplasms | 1 | 1979 | 130 | 0.010 |
Why?
|
| Corynebacterium | 1 | 1977 | 49 | 0.010 |
Why?
|
| Artificial Intelligence | 1 | 2012 | 2666 | 0.010 |
Why?
|
| HIV-1 | 1 | 1995 | 6963 | 0.010 |
Why?
|
| Wales | 1 | 1977 | 87 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 1999 | 361 | 0.010 |
Why?
|
| Drug Eruptions | 1 | 2000 | 335 | 0.010 |
Why?
|
| Cell Transformation, Viral | 1 | 1979 | 530 | 0.010 |
Why?
|
| Genitalia | 1 | 1978 | 114 | 0.010 |
Why?
|
| Kinetics | 2 | 1985 | 6330 | 0.010 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 1 | 1998 | 113 | 0.010 |
Why?
|
| Genes, Lethal | 1 | 1997 | 224 | 0.010 |
Why?
|
| Cooking | 1 | 1999 | 327 | 0.010 |
Why?
|
| Expiratory Reserve Volume | 1 | 1976 | 9 | 0.010 |
Why?
|
| Hematocrit | 3 | 1983 | 623 | 0.010 |
Why?
|
| Therapeutic Irrigation | 1 | 1978 | 297 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2003 | 2661 | 0.010 |
Why?
|
| Lower Extremity | 1 | 2005 | 1217 | 0.010 |
Why?
|
| Pulse | 3 | 1983 | 218 | 0.010 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 1978 | 246 | 0.010 |
Why?
|
| Urinary Bladder | 1 | 1983 | 1157 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 2002 | 1741 | 0.010 |
Why?
|
| Biological Transport | 1 | 1981 | 2085 | 0.010 |
Why?
|
| Gonorrhea | 2 | 1978 | 355 | 0.010 |
Why?
|
| Cuba | 1 | 1996 | 48 | 0.010 |
Why?
|
| Night Blindness | 2 | 1991 | 58 | 0.010 |
Why?
|
| Tibia | 1 | 2002 | 1076 | 0.010 |
Why?
|
| Chlamydia trachomatis | 3 | 1985 | 239 | 0.010 |
Why?
|
| Social Adjustment | 1 | 1998 | 635 | 0.010 |
Why?
|
| Acetals | 1 | 1995 | 5 | 0.010 |
Why?
|
| Genome | 1 | 2004 | 1754 | 0.010 |
Why?
|
| Liver | 3 | 1999 | 7578 | 0.010 |
Why?
|
| Mice, Knockout | 2 | 2004 | 14488 | 0.010 |
Why?
|
| Microsomes, Liver | 1 | 1975 | 174 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2014 | 22380 | 0.010 |
Why?
|
| Diuretics | 1 | 1998 | 614 | 0.010 |
Why?
|
| Neutropenia | 1 | 2000 | 892 | 0.010 |
Why?
|
| Sampling Studies | 2 | 1991 | 615 | 0.010 |
Why?
|
| Self-Assessment | 1 | 1978 | 400 | 0.010 |
Why?
|
| Vitamin A Deficiency | 1 | 1995 | 88 | 0.010 |
Why?
|
| RNA-Binding Proteins | 1 | 2004 | 1891 | 0.010 |
Why?
|
| Cholestyramine Resin | 1 | 1994 | 25 | 0.010 |
Why?
|
| Gemfibrozil | 1 | 1994 | 30 | 0.010 |
Why?
|
| Anesthetics, Local | 1 | 2002 | 1005 | 0.010 |
Why?
|
| Escherichia coli Infections | 1 | 1978 | 524 | 0.010 |
Why?
|
| beta 2-Microglobulin | 1 | 1995 | 330 | 0.010 |
Why?
|
| Castration | 2 | 1987 | 149 | 0.010 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 1995 | 119 | 0.010 |
Why?
|
| Arrhythmias, Cardiac | 2 | 1983 | 2258 | 0.010 |
Why?
|
| Chromosome Deletion | 1 | 1999 | 1385 | 0.010 |
Why?
|
| Premedication | 2 | 1989 | 246 | 0.010 |
Why?
|
| Immunization | 1 | 1998 | 1219 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1998 | 1497 | 0.010 |
Why?
|
| Inspiratory Capacity | 1 | 1993 | 35 | 0.010 |
Why?
|
| Relaxation | 1 | 1974 | 51 | 0.010 |
Why?
|
| Decision Making | 1 | 2008 | 3953 | 0.010 |
Why?
|
| Virulence | 1 | 1997 | 1297 | 0.010 |
Why?
|
| Clindamycin | 2 | 1987 | 138 | 0.010 |
Why?
|
| Niacin | 1 | 1994 | 117 | 0.010 |
Why?
|
| Chlorine | 1 | 1993 | 55 | 0.010 |
Why?
|
| Contraceptive Devices, Female | 2 | 1985 | 39 | 0.010 |
Why?
|
| Mutagenesis | 1 | 1997 | 1228 | 0.010 |
Why?
|
| Hydrogenation | 1 | 1993 | 20 | 0.010 |
Why?
|
| Myocardial Revascularization | 1 | 1997 | 795 | 0.010 |
Why?
|
| Sex Chromosomes | 1 | 1974 | 101 | 0.010 |
Why?
|
| Yoga | 2 | 1974 | 280 | 0.010 |
Why?
|
| Binding Sites, Antibody | 1 | 1993 | 340 | 0.010 |
Why?
|
| Carbohydrate Sequence | 1 | 1993 | 411 | 0.010 |
Why?
|
| Erythema | 1 | 1994 | 261 | 0.010 |
Why?
|
| Student Health Services | 2 | 1985 | 40 | 0.010 |
Why?
|
| Preventive Medicine | 1 | 1994 | 246 | 0.010 |
Why?
|
| Sulfur | 1 | 1993 | 158 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 1997 | 1525 | 0.010 |
Why?
|
| Subarachnoid Hemorrhage | 2 | 1993 | 1024 | 0.010 |
Why?
|
| Cerebrovascular Circulation | 1 | 1983 | 2725 | 0.010 |
Why?
|
| Thrombocytopenia | 1 | 2000 | 1179 | 0.010 |
Why?
|
| Pravastatin | 1 | 1994 | 393 | 0.010 |
Why?
|
| Chromatography, Gas | 1 | 1992 | 150 | 0.010 |
Why?
|
| Activities of Daily Living | 1 | 2002 | 2430 | 0.010 |
Why?
|
| Potassium, Dietary | 1 | 1992 | 103 | 0.010 |
Why?
|
| Pregnancy Trimester, Third | 2 | 1987 | 587 | 0.010 |
Why?
|
| Gentamicins | 2 | 1986 | 244 | 0.010 |
Why?
|
| Hydroxyindoleacetic Acid | 1 | 1992 | 94 | 0.010 |
Why?
|
| Heart | 1 | 1985 | 4446 | 0.010 |
Why?
|
| Blood | 1 | 1975 | 599 | 0.010 |
Why?
|
| Hospitals, Veterans | 1 | 1994 | 395 | 0.010 |
Why?
|
| Protein Binding | 1 | 1984 | 9343 | 0.010 |
Why?
|
| Rabbits | 2 | 1989 | 4773 | 0.010 |
Why?
|
| Gastrointestinal Diseases | 1 | 2000 | 1205 | 0.010 |
Why?
|
| Salmonella typhi | 1 | 1993 | 200 | 0.010 |
Why?
|
| Stereoisomerism | 1 | 1993 | 612 | 0.010 |
Why?
|
| Estradiol Congeners | 1 | 1991 | 22 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 1997 | 2683 | 0.010 |
Why?
|
| Phagocytosis | 1 | 1997 | 1530 | 0.010 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2006 | 3231 | 0.010 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 1998 | 1515 | 0.010 |
Why?
|
| Color Perception | 1 | 1993 | 212 | 0.010 |
Why?
|
| Platelet Function Tests | 1 | 1993 | 275 | 0.010 |
Why?
|
| Candy | 1 | 1991 | 36 | 0.010 |
Why?
|
| Salicylic Acid | 1 | 1991 | 62 | 0.010 |
Why?
|
| Basophils | 1 | 1994 | 407 | 0.010 |
Why?
|
| Anti-Infective Agents | 1 | 1979 | 983 | 0.010 |
Why?
|
| Hip | 1 | 1992 | 256 | 0.010 |
Why?
|
| Salicylates | 1 | 1991 | 128 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2004 | 4413 | 0.010 |
Why?
|
| Temperature | 1 | 1998 | 2234 | 0.010 |
Why?
|
| Interpersonal Relations | 1 | 1998 | 1434 | 0.010 |
Why?
|
| Bacterial Vaccines | 1 | 1973 | 400 | 0.010 |
Why?
|
| Copper | 1 | 1993 | 368 | 0.010 |
Why?
|
| Mercury | 1 | 1993 | 289 | 0.010 |
Why?
|
| Thinking | 1 | 1974 | 320 | 0.010 |
Why?
|
| Cell Cycle | 1 | 1979 | 2934 | 0.010 |
Why?
|
| Skin Tests | 1 | 1993 | 639 | 0.010 |
Why?
|
| Polysaccharides, Bacterial | 1 | 1993 | 582 | 0.010 |
Why?
|
| Head and Neck Neoplasms | 1 | 2005 | 2931 | 0.010 |
Why?
|
| Prothrombin Time | 1 | 1990 | 117 | 0.010 |
Why?
|
| Transfection | 1 | 1998 | 5756 | 0.010 |
Why?
|
| Polysomnography | 1 | 1997 | 1871 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1991 | 417 | 0.010 |
Why?
|
| Methylation | 1 | 1993 | 1078 | 0.010 |
Why?
|
| Cacao | 1 | 1991 | 98 | 0.010 |
Why?
|
| Apolipoproteins B | 1 | 1992 | 386 | 0.010 |
Why?
|
| Lymphocytes | 1 | 1978 | 2614 | 0.010 |
Why?
|
| Arsenic | 1 | 1993 | 358 | 0.010 |
Why?
|
| Individuality | 1 | 1991 | 307 | 0.010 |
Why?
|
| Forecasting | 1 | 1999 | 2945 | 0.010 |
Why?
|
| United States Department of Veterans Affairs | 1 | 1994 | 937 | 0.010 |
Why?
|
| Ampicillin | 2 | 1979 | 137 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1993 | 1890 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 1979 | 2167 | 0.010 |
Why?
|
| Abortion, Spontaneous | 2 | 1985 | 535 | 0.010 |
Why?
|
| Sepsis | 1 | 1983 | 2608 | 0.000 |
Why?
|
| HIV Infections | 1 | 1995 | 17569 | 0.000 |
Why?
|
| Skin Pigmentation | 1 | 1991 | 280 | 0.000 |
Why?
|
| Anticoagulants | 1 | 2004 | 4850 | 0.000 |
Why?
|
| Culture Media | 2 | 1985 | 898 | 0.000 |
Why?
|
| Cephalosporins | 2 | 1979 | 200 | 0.000 |
Why?
|
| Chromosome Disorders | 1 | 1991 | 498 | 0.000 |
Why?
|
| Coronary Artery Bypass | 1 | 1997 | 2191 | 0.000 |
Why?
|
| Urologic Diseases | 1 | 1991 | 246 | 0.000 |
Why?
|
| Airway Resistance | 1 | 1989 | 407 | 0.000 |
Why?
|
| Streptococcus pneumoniae | 1 | 1993 | 764 | 0.000 |
Why?
|
| Maximal Expiratory Flow Rate | 1 | 1987 | 42 | 0.000 |
Why?
|
| Postal Service | 1 | 1988 | 96 | 0.000 |
Why?
|
| Infection Control | 3 | 1979 | 984 | 0.000 |
Why?
|
| Placenta | 1 | 1977 | 1725 | 0.000 |
Why?
|
| Myocardial Ischemia | 1 | 1998 | 2138 | 0.000 |
Why?
|
| Sequence Analysis, DNA | 1 | 1998 | 4786 | 0.000 |
Why?
|
| Linoleic Acids | 1 | 1987 | 39 | 0.000 |
Why?
|
| Iproniazid | 1 | 1966 | 8 | 0.000 |
Why?
|
| Neisseria gonorrhoeae | 2 | 1981 | 249 | 0.000 |
Why?
|
| Serotyping | 2 | 1978 | 331 | 0.000 |
Why?
|
| Polarography | 1 | 1966 | 10 | 0.000 |
Why?
|
| Genetic Testing | 1 | 1980 | 3591 | 0.000 |
Why?
|
| Sisomicin | 1 | 1986 | 5 | 0.000 |
Why?
|
| Netilmicin | 1 | 1986 | 8 | 0.000 |
Why?
|
| Amikacin | 1 | 1986 | 48 | 0.000 |
Why?
|
| Immunoglobulin E | 1 | 1993 | 1506 | 0.000 |
Why?
|
| Marriage | 2 | 1978 | 351 | 0.000 |
Why?
|
| Coronary Vessels | 2 | 1993 | 3124 | 0.000 |
Why?
|
| Tobramycin | 1 | 1986 | 65 | 0.000 |
Why?
|
| Genetics | 1 | 1987 | 114 | 0.000 |
Why?
|
| Mice, Transgenic | 1 | 1998 | 9561 | 0.000 |
Why?
|
| Occupational Medicine | 2 | 1977 | 116 | 0.000 |
Why?
|
| Exercise Test | 1 | 1993 | 2186 | 0.000 |
Why?
|
| NADP | 2 | 1977 | 229 | 0.000 |
Why?
|
| Oxygen Consumption | 2 | 1974 | 1880 | 0.000 |
Why?
|
| Cell Nucleus | 1 | 1974 | 2885 | 0.000 |
Why?
|
| Maine | 1 | 1985 | 146 | 0.000 |
Why?
|
| Enzymes | 1 | 1966 | 254 | 0.000 |
Why?
|
| Guinea Pigs | 1 | 1966 | 1309 | 0.000 |
Why?
|
| Triiodothyronine | 1 | 1966 | 492 | 0.000 |
Why?
|
| Contraception Behavior | 1 | 1986 | 186 | 0.000 |
Why?
|
| Retinol-Binding Proteins | 1 | 1984 | 67 | 0.000 |
Why?
|
| Antibody Formation | 2 | 1979 | 1393 | 0.000 |
Why?
|
| Forced Expiratory Flow Rates | 1 | 1983 | 75 | 0.000 |
Why?
|
| Terminology as Topic | 1 | 1991 | 1542 | 0.000 |
Why?
|
| Sleep Apnea Syndromes | 1 | 1991 | 984 | 0.000 |
Why?
|
| Breech Presentation | 1 | 1983 | 40 | 0.000 |
Why?
|
| Wechsler Scales | 1 | 1983 | 256 | 0.000 |
Why?
|
| Kidney Failure, Chronic | 1 | 1975 | 2496 | 0.000 |
Why?
|
| Bundle of His | 1 | 1983 | 102 | 0.000 |
Why?
|
| Blood Platelets | 1 | 1993 | 2479 | 0.000 |
Why?
|
| Thyroxine | 1 | 1966 | 665 | 0.000 |
Why?
|
| Metacarpus | 1 | 1982 | 37 | 0.000 |
Why?
|
| Extremities | 1 | 1988 | 870 | 0.000 |
Why?
|
| Molecular Weight | 1 | 1985 | 2173 | 0.000 |
Why?
|
| Propranolol | 1 | 1984 | 493 | 0.000 |
Why?
|
| Surgical Procedures, Operative | 2 | 1987 | 1933 | 0.000 |
Why?
|
| Hearing | 1 | 1986 | 504 | 0.000 |
Why?
|
| Uveal Diseases | 1 | 1982 | 45 | 0.000 |
Why?
|
| Catholicism | 1 | 1982 | 32 | 0.000 |
Why?
|
| Color | 1 | 1983 | 296 | 0.000 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 1983 | 137 | 0.000 |
Why?
|
| Ornithine | 1 | 1982 | 79 | 0.000 |
Why?
|
| Skinfold Thickness | 1 | 1982 | 164 | 0.000 |
Why?
|
| Electroencephalography | 1 | 1997 | 6314 | 0.000 |
Why?
|
| Cornea | 1 | 1989 | 1316 | 0.000 |
Why?
|
| Cerebral Hemorrhage | 1 | 1993 | 2654 | 0.000 |
Why?
|
| Cough | 1 | 1985 | 598 | 0.000 |
Why?
|
| Trichomonas Vaginitis | 1 | 1981 | 33 | 0.000 |
Why?
|
| Sympathetic Nervous System | 2 | 1974 | 521 | 0.000 |
Why?
|
| Vaccination | 1 | 1973 | 3437 | 0.000 |
Why?
|
| Obstetric Labor Complications | 1 | 1983 | 244 | 0.000 |
Why?
|
| Nervous System | 1 | 1983 | 544 | 0.000 |
Why?
|
| Vascular Resistance | 1 | 1983 | 939 | 0.000 |
Why?
|
| Penicillin G | 1 | 1979 | 40 | 0.000 |
Why?
|
| Israel | 1 | 1982 | 726 | 0.000 |
Why?
|
| Base Sequence | 1 | 1991 | 12422 | 0.000 |
Why?
|
| Nutritional Requirements | 1 | 1981 | 279 | 0.000 |
Why?
|
| Maximal Midexpiratory Flow Rate | 1 | 1979 | 75 | 0.000 |
Why?
|
| Tetracyclines | 1 | 1979 | 64 | 0.000 |
Why?
|
| Anesthetics | 1 | 1985 | 525 | 0.000 |
Why?
|
| Education | 1 | 1982 | 533 | 0.000 |
Why?
|
| Vaginal Neoplasms | 1 | 1979 | 105 | 0.000 |
Why?
|
| Contraceptive Devices | 1 | 1978 | 25 | 0.000 |
Why?
|
| Pregnancy Trimester, First | 1 | 1983 | 917 | 0.000 |
Why?
|
| Forms and Records Control | 1 | 1979 | 158 | 0.000 |
Why?
|
| Methylcholanthrene | 1 | 1978 | 30 | 0.000 |
Why?
|
| Labor, Obstetric | 1 | 1982 | 323 | 0.000 |
Why?
|
| Hemorrhage | 1 | 1990 | 3466 | 0.000 |
Why?
|
| Methods | 1 | 1978 | 1066 | 0.000 |
Why?
|
| Hot Temperature | 1 | 1985 | 1440 | 0.000 |
Why?
|
| Vaginitis | 1 | 1977 | 50 | 0.000 |
Why?
|
| Enzyme Induction | 1 | 1978 | 455 | 0.000 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 1980 | 352 | 0.000 |
Why?
|
| Genes, Dominant | 1 | 1980 | 855 | 0.000 |
Why?
|
| Wound Infection | 1 | 1979 | 243 | 0.000 |
Why?
|
| Enterococcus faecalis | 1 | 1978 | 244 | 0.000 |
Why?
|
| Aminophenols | 1 | 1978 | 94 | 0.000 |
Why?
|
| Sorbitol | 1 | 1977 | 61 | 0.000 |
Why?
|
| Social Class | 1 | 1986 | 2008 | 0.000 |
Why?
|
| Deuterium | 1 | 1977 | 106 | 0.000 |
Why?
|
| Hand | 1 | 1982 | 913 | 0.000 |
Why?
|
| Contraceptive Agents | 1 | 1978 | 148 | 0.000 |
Why?
|
| Vulvar Neoplasms | 1 | 1979 | 266 | 0.000 |
Why?
|
| Leukemia | 1 | 1985 | 1519 | 0.000 |
Why?
|
| Urethra | 1 | 1978 | 406 | 0.000 |
Why?
|
| Atrophy | 1 | 1982 | 1646 | 0.000 |
Why?
|
| Fathers | 1 | 1979 | 377 | 0.000 |
Why?
|
| Penicillins | 1 | 1979 | 406 | 0.000 |
Why?
|
| Liver Diseases | 1 | 1985 | 1305 | 0.000 |
Why?
|
| Urban Health | 1 | 1978 | 535 | 0.000 |
Why?
|
| Acetaldehyde | 1 | 1975 | 39 | 0.000 |
Why?
|
| Antibody Specificity | 1 | 1978 | 1065 | 0.000 |
Why?
|
| Graft Rejection | 1 | 1989 | 4492 | 0.000 |
Why?
|
| Coloring Agents | 1 | 1978 | 564 | 0.000 |
Why?
|
| Peptococcus | 1 | 1975 | 5 | 0.000 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 1983 | 957 | 0.000 |
Why?
|
| Propionibacterium | 1 | 1975 | 4 | 0.000 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 1977 | 209 | 0.000 |
Why?
|
| Drug Resistance, Microbial | 1 | 1978 | 830 | 0.000 |
Why?
|
| Candida albicans | 1 | 1978 | 375 | 0.000 |
Why?
|
| Isotope Labeling | 1 | 1977 | 394 | 0.000 |
Why?
|
| Cervix Uteri | 1 | 1979 | 577 | 0.000 |
Why?
|
| Catalase | 1 | 1975 | 215 | 0.000 |
Why?
|
| Diet Fads | 1 | 1974 | 14 | 0.000 |
Why?
|
| Haplorhini | 1 | 1975 | 523 | 0.000 |
Why?
|
| Staphylococcus | 1 | 1975 | 146 | 0.000 |
Why?
|
| Streptococcus | 1 | 1975 | 198 | 0.000 |
Why?
|
| Quinacrine | 1 | 1974 | 24 | 0.000 |
Why?
|
| Molecular Conformation | 1 | 1975 | 540 | 0.000 |
Why?
|
| Social Conditions | 1 | 1974 | 121 | 0.000 |
Why?
|
| Anesthesia, Obstetrical | 1 | 1976 | 235 | 0.000 |
Why?
|
| Infant, Newborn, Diseases | 1 | 1979 | 587 | 0.000 |
Why?
|
| Membranes | 1 | 1974 | 164 | 0.000 |
Why?
|
| Psychophysiology | 1 | 1974 | 137 | 0.000 |
Why?
|
| Bacteriological Techniques | 1 | 1975 | 277 | 0.000 |
Why?
|
| Emphysema | 1 | 1976 | 236 | 0.000 |
Why?
|
| Cell Nucleolus | 1 | 1974 | 156 | 0.000 |
Why?
|
| Fetal Death | 1 | 1975 | 434 | 0.000 |
Why?
|
| Vaginal Smears | 1 | 1975 | 505 | 0.000 |
Why?
|
| Airway Obstruction | 1 | 1976 | 672 | 0.000 |
Why?
|
| Mouth Mucosa | 1 | 1974 | 437 | 0.000 |
Why?
|
| Monitoring, Physiologic | 1 | 1979 | 1798 | 0.000 |
Why?
|
| Kidney | 1 | 1986 | 7064 | 0.000 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 1977 | 951 | 0.000 |
Why?
|
| Cerebral Cortex | 1 | 1966 | 5812 | 0.000 |
Why?
|
| Mass Spectrometry | 1 | 1977 | 2202 | 0.000 |
Why?
|
| Wakefulness | 1 | 1976 | 1284 | 0.000 |
Why?
|
| Oxidation-Reduction | 1 | 1975 | 2227 | 0.000 |
Why?
|
| Hypothalamus | 1 | 1974 | 1004 | 0.000 |
Why?
|
| Heart Ventricles | 1 | 1980 | 3841 | 0.000 |
Why?
|
| Delivery, Obstetric | 1 | 1975 | 954 | 0.000 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 1979 | 2043 | 0.000 |
Why?
|
| Escherichia coli | 1 | 1978 | 4213 | 0.000 |
Why?
|
| Patient Discharge | 1 | 1979 | 3479 | 0.000 |
Why?
|
| Fluorescent Dyes | 1 | 1974 | 1931 | 0.000 |
Why?
|
| Brain | 1 | 1983 | 27362 | 0.000 |
Why?
|